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Zinc has been identified as one of the most promising biodegradable metals along with magnesium and
iron. Zinc appears to address some of the core engineering problems associated with magnesium and iron
when applied to biomedical implant applications; hence the increase in the amount of research investi-
gations on the metal in the last few years. In this review, the current state-of-the-art on biodegradable Zn,
including recent developments, current opportunities and future directions of research are discussed. The
discussions are presented with a specific focus on reviewing the relationships that exist between
mechanical properties, biodegradability, and biocompatibility of zinc with alloying and fabrication tech-
niques. This work hopes to guide future studies on biodegradable Zn that will help in advancing this field
of research.
Statement of Significance
(i) The review offers an up-to-date and comprehensive review of the influence of alloying and fabrication
technique on mechanical properties, biodegradability and biocompatibility of Zn; (ii) the work cites the
most relevant biodegradable Zn fabrication processes including additive manufacturing techniques; (iii)
the review includes a listing of research gap and future research directions for the field of biodegradable
Zn.
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Metals have a long history of use as an implant material in
the medical field [1–7]. The attraction of using metals is attribu-
ted to their unique combination of properties including good
mechanical strength, ductility, toughness, wear resistance and
formability. From a biocompatibility standpoint, the first genera-
tion of metallic materials used for implant applications was
required to be inert in the physiological environment [5–7].
Some of these metals include stainless steels (316L), cobalt-
chromium (CoCr) alloys, and titanium (commercially pure Ti)
and Ti alloys (e.g., Ti-6Al-4V). Good corrosion resistance was nec-
essary to ensure excellent biocompatibility by preventing the
possible complications associated with the interaction of corro-
sion products and human cells.
Recently, biodegradable and bioabsorbable metals such as mag-
nesium (Mg), iron (Fe) and zinc (Zn) have found increasing accep-
tance as an implant material [8–15]. Three words that are typically
associated with these metals are ‘biodegradable’, ‘bioabsorbable’,
and ‘bioresorbable’, and it may be useful to distinguish between
these terms. Researchers have used these terms interchangeably,
but Liu et al. [16] recently expounded on the proper use of these
modifiers. A biodegradable metal is a material that degrades by a
biologically-mediated process, such as enzymatic and cellular pro-
cesses. The term ‘biodegradable’ is not only associated with the
degradation of materials within the body but could also be used
to describe those occurring in the natural, external environment.
It is the most frequent modifier used for describing metals and
polymers of such kind. A bioabsorbable metal is expected to
decompose via similar biological pathways as a biodegradable
metal, such as those encountered in the physiological environment
of the body, but without the host eliciting a negative response from
its degradation products. Hence, ‘bioabsorbable’ focuses more on
how a host metabolizes or assimilates a material’s degradation
products. A bioresorbable metal degrades in vivo, and is removed
either by a cellular activity or other processes. Though very similar
to bioabsorbable in meaning, the term ‘bioresorbable’ has long
been associated with biological reaction, specifically relating to
osteoclast-driven bone resorption processes. Liu et al. suggested
that ‘resorbable’ is best used to describe implants that have the
potential to allow affected tissues to grow back to its original form
(e.g., bone scaffolds).cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
and biocompatibility of zinc: A comprehensive review, Acta BiomateriaLiu et al. [16] concluded that ‘absorbable’ is the most appropri-
ate modifier for describing implants that are expected to dissolve
safely in the body. This term is adopted by standards (e.g., ASTM,
ISO), is the most historically established, and the most broadly
applicable to medical applications. However, since the term
‘biodegradable’ has found considerable use for describing biomet-
als such as Mg, Fe and Zn, then in this review, we retain the use of
‘biodegradable’ and will use it interchangeably with
‘bioabsorbable’.
A bioabsorbable implant is anticipated to dissolve completely
once tissue healing is accomplished. Thus, it is reasonable to
assume that this should consist of elements that are safely metab-
olized by the body and preferably those that are essential to
human functions. The biodegradable implant should also degrade
at an appropriate rate so that it can extend the necessary support
to the tissue for the duration that such help is warranted.
Biodegradable metals have already been considered for medical
applications for many years, though it is likely that these were pre-
viously used without the advantages of biodegradability in mind.
For example, a functional wrought Fe dental implant was found
in a corpse dated to the first or second century AD [17]; in the
17th century, the pioneering anatomist and surgeon Hieronymus
Fabricius used Fe sutures to treat soft tissue defects [11]; and, in
1878, Edward Huse used pure Mg sutures to stitch broken blood
vessels [8].
Of the three candidate metals, Zn is the most recently intro-
duced [9]. The bulk of the publications on this topic have only been
available in the last five years. Research suggests that some of the
issues related with Mg and Fe may be addressed by using Zn
[18,19]; hence the considerable increase in scientific interest on
this metal.
Literature reviews on biodegradable Zn are already available
[20–23], and one of the most-cited is that by Bowen et al. [21] pub-
lished in 2016. Bowen et al. reviewed the state-of-the-art in
biodegradable stenting and biodegradable Zn research. However,
their review of the literature on Zn covered those that were pub-
lished before 2016, and a substantial number of research findings
on the topic have been published since this time. Recently, Mos-
taed et al. [23] published a review that focused on biodegradable
Zn for vascular applications. The current review builds on these
works, presents updates on recent developments, and provides
some framework for future scientific engagements. This work aimsying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
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with a specific focus on reviewing the relationship of properties,
such as mechanical properties, biodegradability, and biocompati-
bility, with alloying and fabrication techniques. Both traditional
and advanced fabrication techniques, such as additive manufactur-
ing (AM) or 3D printing, will be included in the discussions. Also,
though an exhaustive citation of microstructures attendant to each
Zn alloy is not included, discussions highlighting the
microstructure-property relationship are present. This review
hopes to guide future researchers on topics that will help in the
advancement of the field. A mature understanding of the work
done on some of the early biodegradable metals such as Mg and
Fe will be beneficial, though this is beyond the scope of the current
work, and will give the reader a better appreciation of the work
presented herein.2. Zinc as a potential bioabsorbable metal
2.1. Requirements of a biodegradable metal for stent and bone-fixation
device
Biodegradable metals are most suitable in implants requiring
temporary functions in the body. Two promising medical applica-
tions of bioabsorbable metals are in the fabrication of stents and
orthopedic fixation devices. A stent is a miniature tube that is
placed into a hollow bodily structure, such as a blood vessel or a
urethra [24]. The primary function of the stent is to keep the hol-
low structure open and relieve constrictions. The stent may be
delivered using different medical procedures, such as the percuta-
neous coronary intervention (PCI) to treat heart artery stenosis
[25]. In orthopedics, an internal fixator is an implant that is used
to guide the healing process of bone fractures. The implant stabi-
lizes the fractured bone, thus preventing motion across fracture
lines and allowing rapid healing of damaged structures. Orthopedic
internal fixators may come in the form of plates and screws, wires
(e.g., Kirschner wires), and nails (e.g., intramedullary rod) [26].
The current materials of choice for metallic stents are 316L
stainless steel, nickel-titanium alloy (NiTi or Nitinol), tantalum
(Ta) and the CoCr alloy [27,28]. Metallic stents may be deployed
bare or drug-eluting. Drug-eluting stents (DES) are bare stents
coated with a drug that is slowly released during service [29,30].
It is said that the introduction of the DES allowed the PCI to
become one of the most frequently performed therapeutic inter-
ventions in medicine [30]. DES addressed the problem of in-stent
restenosis (i.e., growth of tissue on the stent that results to channel
blocking) associated with bare stents. Restenosis refers to the
growth of tissue on the stent that results in channel blocking.Table 1
Specific design constraints for a biodegradable material considered for stent and bone-fix
Criterion Stent
Biocompatibility  Non-toxic, non-inflammatory, hypoallerg
 no harmful release or retention of partic
 promote endothelial cell attachment; d
muscle cell attachment
Mechanical integrity and resorption
during service
 Mechanical integrity 3–6 months
 Full absorption in 1–2 years
Mechanical properties  Yield strength > 200 MPa
 Tensile strength > 300 MPa
 Elongation to failure > 15–18%
 Elastic recoil on expansion < 4%
Corrosion behaviour  Penetration rate < 20 lm year1
 Hydrogen evolution < 10 lL cm2 per day
Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta BiomateriaRestenosis is attributed to a vascular repair process called neointi-
mal hyperplasia. Correcting neointimal hyperplasia would require
repeat revascularization [29], a procedure that adds to a patient’s
distress and expenses.
However, the fact that metallic stents remain permanently in
the artery also creates several issues. One of the most serious is
the occurrence of late stent thrombosis (i.e., blocking of the blood
vessel due to a blood clot or thrombus) that requires long-term
antiplatelet treatment [31]. A bioabsorbable stent has the potential
to reduce or eliminate these shortcomings associated with bare and
drug-eluting metallic stents. A dissolving stent ensures (i) a low
stent profile regardless of tissue growth, (ii) minimal platelet accu-
mulation and thrombus proliferation, (iii) the restoration of vaso-
motion, (iv) the prevention of strut-fracture induced restenosis,
(v) freedom from side branch obstruction by the struts, and (vi)
the possibility of repeat treatments on the same vascular site [31].
For bone fixation implants, the biocompatible metals include
stainless steels (SS), cobalt alloys, titanium (Ti) and Ti alloys [32].
The use of metal-based fixation devices is related to particular
issues including stress shielding, corrosion and stress-corrosion
cracking (SCC), accumulation of implant metal in tissues, interfer-
ence in radiological studies, and need of additional surgery for
implant removal [33]. Of these issues, the need for an extra opera-
tion to remove the implant is the most distressing to a patient.
With a biodegradable implant, the necessity for implant removal
procedures is eliminated as the implant is expected to eventually
dissolve in the body.
A biodegradable material is required to possess specific proper-
ties before it becomes viable for stent and orthopedic-fixation
device fabrication. Table 1 lists some of the recognized design con-
siderations specific to these two applications [12,18,21,34]. The
first and most important attribute is that the material along with
its degradation products should be innocuous and compatible in
the physiological environment [9,27].
Bioabsorbable stents are designed to act as a supporting struc-
ture or scaffold to the walls of the blood vessel during the remod-
elling period and to slowly dissolve as the tissue heals and
regenerate [21,36]. Ideally, these devices must retain mechanical
properties for approximately 3–6 months before being broken
down and safely processed by the body [21,37,38]. It was sug-
gested that the mechanical properties of the candidate materials
should approximate those of 316L stainless steel, a metal that
has been traditionally considered as the gold standard for stents
[21,39], with the advantage of permitting clinicians to possess rea-
sonable deployment expectations when using the biodegradable
stent [21].
Table 1 also indicates that the property requirements for an
orthopedic fixation device are essentially similar to those requiredation device applications [12,18,21,34,35].
Orthopedic internal fixation device
enic
ulates
iscourage smooth
 non-toxic, non-inflammatory, hypoallergenic
 no harmful release or retention of particulates
 promote osteoblast and osteoclast attachment; avoid
fibrous encapsulation
 Mechanical integrity:
◦ Plates and screws < 6 mos
◦ Osteotomy staples < 3 mos
 Full absorption in 1–2 years
 Yield strength > 230 MPa
 Tensile strength > 300 MPa
 Elongation to failure > 15–18%
 Elastic modulus approximate to that of cortical bone
(10–20 GPa)
 Plates and screws (0.5 mm year-1)
 Hydrogen evolution < 10 lL cm2 per day
ying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
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fixation need to retain their mechanical integrity longer than those
used in stent applications. This is reasonable since bone fixation
devices are often load-bearing, and may even encounter complex
loading profiles during service. Furthermore, one particular prop-
erty where orthopedic device manufacturers place a premium on
is elastic modulus. The elastic modulus of potential resorbable
bone scaffolds needs to be close to that of cortical bone to avoid
stress-shielding [40].
2.2. The case for Zn
In the search for bioabsorbable implant material, two types of
materials have found considerable acceptance in the scientific
community. The first type is the polymer, with in vitro biocompat-
ibility studies on polyglycolic acid/polylactic acid (PGA/PLA), poly-
caprolactone (PCL), polyhydroxybutyrate valerate (PHBV),
polyorthoester (POE), and polyethyleneoxide/polybutylene tereph-
thalate (PEO/ PBTP) being some of the first to be reported [41–43].
These studies eventually led to the development of commercial
bioabsorbable implants. Examples include the Igaki-Tamai, the
DESolve, and the ABSORB stents made of poly-L-lactic acid (PLLA)
[44]; the Ideal BioStent consisting of salicylic acid/adipic acid
(SA/AA); and the REVA stent constructed from tyrosine-derived
polycarbonate [14,31]. Reports on the successful application of
polymer-based bioabsorbable screws for bone grafting fixation
are also available [45].
The second class of bioabsorbable materials are metals. Table 2
presents a summary of the advantages and disadvantages of the
most promising biodegradable metals, Mg, Fe and Zn. These metals
are considered essential micronutrient of the body, and Table 2
includes the recommended daily intake (RDI) for each metal. The
RDI is suggested to be a key measure for assessing a material’s bio-
compatibility [11].
Magnesium has a long history of successful use as an implant
material, though early applications considered its biodegradability
as a disadvantage [9]. Magnesium offers excellent biocompatibility
as indicated by its high RDI. It has good mechanical properties, par-
ticularly having an elastic modulus that approximates that of
human bone. The boom in Mg research came about with the
renewed interest in the idea of degradable metals. Currently, mag-
nesium and its alloys (e.g., Mg-Ca, Mg-Zn, Mg-Si, Mg-Sn, Mg-Zr,
Mg-Al, Mg-Y, andMg-REE) are the most widely studied and consid-
ered the most promising among the bioabsorbable metals
[8,9,46,47]. In fact, in 2016 BIOTRONIK released the first commer-
cially available, clinically proven, sirolimus-eluting bioabsorbable
magnesium stent [48,49].Table 2
Advantages and disadvantages of magnesium, iron, and zinc-based biodegradable metals
Biodegradable
Metal
Recommended Daily
intake, mg
Advantages
Mg 375–700  Excellent biocompatibility
 Compact corrosion product
 Good strength
 Low density and elastic modul
properties)
 MRI compatible
Fe 10–20  Good biocompatibility
 Excellent strength and formabil
 MRI compatible (austenitic pha
 No gas generated during degrad
Zn 6.5–15  Good biocompatibility
 Corrosion rate in between Mg a
 No gas generated during degrad
 Low melting point and low rea
state
Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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materials to be tested in vivo after early reports on biodegradable
polymers cast doubts on the polymers’ biocompatibility [50]. Stud-
ies on bioabsorbable Fe and some Fe alloys such as Fe-Mn, Fe-W,
and Fe-Mg soon followed and attracted a lot of research attention
[51–53]. Fe offers excellent mechanical strength, ductility, and
formability, and good biocompatibility. Recently, Lifetech Scientific
created IBS [54], a sirolimus-eluting, iron-based coronary scaffold.
This stent is now undergoing clinical testing in humans.
Though Mg and Fe have a head start in this field [9,12,13], the
scientific community continues to look for other alternatives con-
sidering that both metals still have issues. Zinc and its alloys are
promising alternatives as they seem to address some of the funda-
mental engineering issues associated with the use of biodegradable
Mg and Fe.
In an arterial environment, the natural biocorrosion rate of pure
Mg extends to the hundreds of micrometers per year, while high-
purity Zn degrades at a rate of tens of micrometers per year [18].
The lower corrosion rate of Zn presents several advantages. For
example, Bowen et al. [21] suggested that for stent applications,
the low biocorrosion rate of Zn (i) offers greater freedom for met-
allurgical manipulation and consequent strengthening, (ii) better
biocompatibility, and (ii) allows the engineering of lower profile
stents that is crucial to limiting restenosis and thrombosis. Another
advantage of Zn over Mg is that its corrosion process does not gen-
erate hydrogen gas. There are some concerns with the potential
harm that this corrosion by-product poses to the body, such as
the formation of gas pockets around the disintegrating implant,
though this issue is still debatable [56,57].
The issues with ferrous biometals stem from its relatively low
corrosion rate and the production of insoluble, albeit biocompati-
ble, corrosion product [9,58,59]. The slow corrosion rate of iron
implies that the implant stays longer than necessary in the body.
Pierson et al. [60] also noted that the biocorrosion product of Fe
could remain encapsulated in the neointima (or new arterial lin-
ing) in an expanded form that could interfere with arterial func-
tion. Zn has the potential to avoid these problems by having a
higher corrosion rate than Fe and possessing a compact and bio-
compatible corrosion product similar to that of Mg [18].
Others cite that another advantage of Zn is its low melting point
and low reactivity in the molten state [55]. This allows Zn to be
fabricated and shaped by simple techniques such as casting and
hot wrought processing.
While the full extent of some critical properties (e.g., mechani-
cal properties, corrodibility, and biocompatibility) of biodegrad-
able Zn is only recently being discovered, the benefits of Zn to
human physiology are relatively well known. In ancient times,[9,11,12,15,23,55].
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Fig. 1. Schematic showing the different Zn alloy combinations studied for biodegradable implant applications.
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medicinal creams [61]. Zinc is counted as an essential trace ele-
ment and plays catalytic, structural and regulatory roles in the
human cell [61,62]. Bowen et al. [21] reviewed the many physio-
logical functions of Zn including: (i) having a direct signalling func-
tion at different cellular levels; (ii) is necessary for the function of
more than 300 enzymes involved in diverse physiological pro-
cesses such as wound healing, brain development, and cell mem-
brane stability; (iii) is vital to the structure of a number of
proteins, plays a regulatory role by inhibiting and activating
enzymes and proteins; (iv) is an essential component in chromatin
structure; (ii) plays a role in DNA replication and repair; (v) acts as
an antioxidant via the stabilisation of DNA and cell membranes;
(vi) is an antiatherogenic; and (vii) improves endothelium integrity
and prevents atherosclerosis.
Several studies have also observed the positive influence of the
presence of Zn in different biomimetic ceramic scaffolds including
hydroxyapatite, nano-hydroxyapatite, carbonated hydroxyapatite,
biphasic calcium phosphate and tricalcium phosphate [63,64]. Zinc
in calcium phosphate-based scaffolds was found to be completely
biocompatible, induces rapid bone repair, and reduces bone
resorption [63].
Zinc is not without its issues. Zn possesses relatively lower
mechanical properties than Mg and Fe, which raises concerns on
its ability to sustain applied loads and maintain post-corrosion
structural integrity during service. Concerning toxicity, Zn is less
biocompatible than Mg [65], but is very similar to Fe, as seen by
comparing the RDI of each element in Table 2. Some Zn alloys [66]
appear to trigger a slight cytotoxic response in healthy human cells.
Zinc overdose or chronic overexposure (i.e., 100–300 mg day1) can
cause nausea, vomiting, abdominal pain, diarrhea, fatigue, and sev-
ere copper deficiency [67]. An excess of Zn is considered neurotoxic,
can impair immune function, and may delay bone development
[9,67]. These issues need to be addressed before the adoption of
Zn in biodegradable implant technology in the future.
3. Development of zinc and zinc alloys for biomedical
applications
Research on biodegradable Zn and Zn alloys for biomedical
application is relatively new, with a majority of the work published
in the last five years.
However, some of the earliest mention of Zn as a potential
biodegradable implant include those by (i) Bolz and Popp [68],
who suggested, in a patent in 2001, the feasibility of bioabsorbable
coronary stents made of pure Zn and some Zn-X(X= Ti, Ca) alloys;
and by (ii) Wang et al. [69] in 2007.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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for biomedical applications. A wide range of composition has
already been studied; namely, (i) pure Zn, (i) binary, (iii) ternary,
and (iv) quaternary combinations of Zn with other elements. The
following section describes the development of these Zn and Zn
alloys for biomedical applications.
3.1. Pure Zn
In 2011, Vojtech et al. [19] published what appears to be the
first study on biodegradable Zn (99.95%) and other Zn alloys and
essentially started the formal research on the use of this metal
for bioabsorbable implant applications. They observed from
in vitro biodegradability tests that Zn indeed corrodes in a physio-
logical fluid. Also, though they did not perform any biocompatibil-
ity tests, they noted that the dose of Zn ions released via corrosion
is negligible compared to the maximum tolerable biological limit.
They then concluded that Zn will not likely elicit a toxic response
if used as an implant and is, therefore, a possible alternative to
Mg-based biodegradable alloys. Subsequently, Cheng et al. [70]
compared the in vitro corrosion performance of five pure metals;
namely, Mg, Fe, Zn, manganese (Mn), and tungsten W, and simi-
larly gave positive conclusions on the biocompatibility of Zn. In
2013, Bowen et al. [18] published their landmark study on the
in vivo performance of pure Zn (99.99%+) using a small animal
model. The study looked at the in vivo corrosion behaviour and
biocompatibility of a commercial Zn wire inserted in the abdomi-
nal aorta of Sprague-Dawley rats. They observed that the Zn wire
remained intact for at least four months, after which time corro-
sion began to accelerate. More importantly, Bowen et al. found
the good in vivo biocompatibility of Zn and concluded that Zn is
highly suitable for bioabsorbable cardiac stent applications. In
the succeeding years, Bowen et al. [71], Drelich et al. [72,73], and
Guillory et al. [74] further contributed knowledge on the in vivo
performance of pure Zn.
Other notable works on pure Zn include: (i) the fabrication of
ultrapure (6 N) Zn minitubes by Liu et al. [75]; (ii) the manufacture
of a functional Zn (4 N) stent by Hiebl et al. [76]; (iii) studies on the
feasibility of using additive manufacturing techniques to form Zn
by Demir et al. [77], Yang et al. [78], and Wen et al [79,80]; (iv) a
study on the in vitro degradation of Zn (99.9%) in saline solutions,
plasma and whole blood by Torne et al. [81,82]; (v) studies on the
influence of Zn+2 ions on the in vitro viability of human cells by Ma
et al. [83] and Shearier et al. [84]; (vi) a study on the in silico,
in vitro and antifungal activity of surface corrosion products
formed during the biodegradation of Zn by Alves et al. [85]; and
(vii) a long-term study on the in vivo degradation of an actual Znying and fabrication techniques on the mechanical properties, biodegrad-
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would often characterize pure Zn as this serves as the control in the
respective experiments.
3.2. Binary alloys
The primary purpose of adding alloying elements to Zn is to
alter two properties: (i) mechanical properties and (ii) biocorrosion
properties. The most logical approach to Zn alloying for biomedical
application is to combine it with elements that are known to be
biocompatible or essential to human function, such as Mg, Ca,
and Cu. Magnesium is the most well-known and the most studied
biodegradable metal. It is therefore not surprising that a substan-
tial number of studies looked at the combination of Mg and Zn.
Vojtech et al. [19], in 2011, were the first to report on the use of
Zn-Mg alloy for bone fixation applications. Development of binary
Zn alloys continued with notable works by Zheng and co-workers
[87,88] on Zn-Mg, as well as zinc-calcium (Zn-Ca), and zinc-
strontium (Zn-Sr) alloys. Other reports on Zn-Mg include those
by Kubasek et al. [55,89,90], Yao et al. [91],Gong et al. [92], Murni
et al. [93], Shen et al. [94], Galib and Sharif [95], Mostaed et al. [96],
Jablonska et al. [97], Dambatta et al. [98,99], Vida et al. [100],
Jarzebska et al. [101], Jin et al. [102], Xiao et al. [103], Alves et al.
[104], Wang et al. [105], and Yang et al. [78]. The range of Mg addi-
tion typically ranged from 1 to 3 wt%; though relatively high (>5%)
[90] and low (<0.1 wt%) [102,103] alloy additions of Mg have also
been reported.
Research on other binary combinations have also been reported,
including zinc-copper (Zn-Cu) [66,106], zinc-lithium (Zn-Li)
[107,108], zinc-aluminium (Zn-Al) [74,96,109], zinc-silver (Zn-
Ag) [110,111], and zinc-manganese (Zn-Mn) [112,113].
3.3. Ternary alloys
Vojtech et al. [19] were also the first to report on the biocom-
patibility of a Zn ternary alloy; i.e., zinc-aluminium-copper (Zn-
Al-Cu). Studies on other ternary combinations were similarly pur-
sued, with most of these based on the Zn-Mg combination. Some of
the reported Zn-Mg-based ternary alloys include zinc-magnesium-
iron (Zn-Mg-Fe) [114], zinc-magnesium-strontium (Zn-Mg-Sr)
[88,115], zinc-magnesium-calcium (Zn-Mg-Ca) [88], and zinc-
magnesium-manganese (Zn-Mg-Mn) [116]. Again, using Zn-Mg
as a base for the ternary alloy makes sense, since this binary com-
bination is the most studied owing to its expected good biocom-
patibility. Reports on Mg additions to binary alloys of Zn-Cu
[117] and Zn-Al [118] are also available.
There are also studies on ternary combinations that do not
involve the Zn-Mg pair, including zinc-calcium-strontium (Zn-Ca-
Sr) [88], zinc-manganese-copper (Zn-Mn-Cu) [119], zinc-copper-
iron (Zn-Cu-Fe) [120], and zinc-aluminium-strontium (Zn-Al-Sr)
[121].
3.4. Quaternary alloys
Currently, there are few reports on the use of Zn quaternary
alloys. Only a single study may be cited; i.e., the study by
Bakhsheshi-Rad et al. [122] that looked at the zinc-magnesium–alu
minium-bismuth (Zn-Mg-Al-Bi) combination. The lack of studies
on quaternary combinations may be due to several factors. Firstly,
there is still considerable work that needs to be accomplished in
the binary and ternary Zn alloys; hence, the development of these
less complex alloy systems has reasonably attracted the attention
of most researchers. Secondly, it is quite logical to limit the number
of elemental constituents in an alloy to reduce fabrication cost and
simplify manufacturing methods.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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Some commercially-available Zn alloys have also been studied
as a possible biodegradable implant material. Commercial alloys
offer the distinct advantage of good accessibility and predictable
composition. Wang et al. [123] investigated the biodegradability
and biocompatibility of ZA4-1 (3.5–4.5 Al, 0.75–1.25 Cu, 0.03–
0.08Mg), ZA4-3 (3.5–4.3Al, 2.5–3.2 Cu, 0.03–0.06Mg) and ZA6-1
(5.6–6.0 Al, 1.2–1.6 Cu) Zn alloys, while Kannan et al. [124] studied
similar properties in Zn-5Al-4 Mg.4. Fabrication techniques for biodegradable zinc
The choice of the fabrication process is crucial as this can influ-
ence the microstructure and the inherent properties of Zn. The fol-
lowing identifies and describes some of the processes adopted to
create biodegradable Zn, including traditional techniques such as
casting and wrought processing, and advanced processes such as
powder metallurgy and additive manufacturing.
4.1. Casting
The most common method for the fabrication of the Zn alloy is
via casting [19,87,89,92,95] since it allows easy customization of
the alloy composition. The process involves heating the metal com-
ponents above their melting temperatures (typically between 470
and 750 C depending on alloy composition) in a protective envi-
ronment (e.g., Ar, SF6, CO2, or vacuum), pouring the liquid metal
into appropriate molds (e.g., steel or graphite), and allowing the
metal to solidify. The conventional melting furnaces used are resis-
tance and induction furnaces.
Since the purpose of most studies was to apply zinc as a
biomedical implant, then the metal should be in the shape that
approximates service form. For example, bone fixation devices
need flat plates, while stents require thin-walled cylindrical tubes.
Casting is not appropriate for generating such net shapes. How-
ever, the as-cast metal is still useful as it serves as the raw material
for the ensuing forming processes that create the desired product
profile.
4.2. Traditional wrought techniques
In metal processing, wrought techniques refer to processes that
use an applied mechanical force to plastically deform a metal and
create the desired shape [125]. The term wrought means ‘worked’,
a reference to the mechanical nature of the process. Wrought pro-
cessing may be done hot or cold depending on the relationship of
the working temperature with the recrystallization temperature
of the metal. If the metal is plastically shaped above its recrystal-
lization temperature, then this is referred to as hot working. Other-
wise, it’s cold working. The most popular wrought techniques
include rolling, forging, extrusion, and drawing.
In most studies on biodegradable Zn, the primary method to
create a flat profile is via hot rolling [87,108,109,119]. Hot rolling
involves the passing of a heated metal stock through a pair of rolls
to reduce thickness. The rolling process for Zn is often preceded by
a homogenization treatment, which consists of heating the metal
at 250–350 C for 30–180 min, to attain a uniform composition in
the pre-formed Zn. The thickness of the rolled product can range
from a few millimeters to about 300 lm.
The elongated cylindrical profile typical of a tube may be cre-
ated via extrusion [19,66,87,94,96,103,105,106,110,112] or draw-
ing [75,107,114]. Extrusion involves pushing the metal through a
die with an orifice of the desired shape. Extrusion can be direct
or indirect. In direct extrusion, the die is stationary, and the billetying and fabrication techniques on the mechanical properties, biodegrad-
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is mobile and is pushed into the billet causing the metal to flow
through the die orifice. Drawing is similar to extrusion except that
the metal is pulled through the die instead of being pushed. In both
processes, the metal is often pre-heated at 180–300 C for 30–
180 min before shaping. Extrusion is also typically used as the pre-
liminary forming step prior to further reduction by drawing
[102,105,107]. Hollow tubes may also be fabricated via extrusion
or drawing, often with the use of appropriate mandrels. Wang
et al. [114] used hollow sinking and mandrel drawing to create
microtubes with a diameter of 2.5 mm and thickness of 130 lm.
Hollow sinking involves drawing the rolled tube through a drawing
die, while mandrel drawing consists of drawing the tube through
the gap between the mandrel and the die.4.3. Advanced processing techniques
There are some published reports on the application of novel
fabrication techniques to create biodegradable Zn.
Vida et al. [100] used an advanced solidification technique
called directional solidification casting to create cast Zn with some
interesting microstructures. The process is a modification on tradi-
tional casting and uses a water-cooled mold that was designed to
promote directional solidification by controlling heat flow
conditions.
Jarzebska et al. [101] produced 5 mm diameter Zn rods using
cold hydrostatic extrusion, a type of extrusion where the billet is
circumscribed in a pressurized fluid. The fluid pressure was main-
tained between 470 and 500 MPa and the strain rate was set to 4–
40 s1.
Dambatta et al. [98] used equal-channel angular pressing
(ECAP), which is a type of severe plastic deformation process that
involves metal billet being pressed through an angled (e.g., 90)
channel. They used dies with an 8  8 mm channel cross section
and an intersection angle of 120 C. The strain rate was 1 mm s1.
The dies were heated to 200 C, and molybdenum disulphide lubri-
cant was used to reduce friction loads.
Powder metallurgy (P/M) techniques have also been used to
fabricate biodegradable Zn. Sotoudeh Bagha et al. [113] prepared
dense Zn-Mn disks via mechanical alloying of corresponding pow-
ders, followed by uniaxial cold-pressing and sintering. The milling
process was done for 20 h under an argon atmosphere, and a ball-
to-powder weight ratio of 20:1. Cold pressing of the alloy powders
was done at a pressure of 300 MPa, while sintering was set at 250
and 450 C for 1 h.
The fabrication of porous Zn is also attractive as this material
may be useful for some biomedical applications, particularly in
the manufacture of bioresorbable, tissue-engineered bone scaf-
folds. Capek et al. [126] used spark plasma sintering to create por-
ous Zn. Spark plasma sintering is a technique that uses a pulsed
direct current (DC) applied to a powder compact to induce densifi-
cation. The team used low compacting pressures (5 MPa) to accom-
modate greater pore volume in the powder compact. An average
porosity of about 20% was measured in the final product. Hou
et al. [127] used hot press sintering (HPS) of salt (NaCl) templates
followed by pressure infiltration casting to create porous
biodegradable Zn-scaffolds. The produced scaffolds were hierarchi-
cal, open porous structure consisting of central and interconnected
pores, and with porosity volume of up to 75%. Yang et al. [128]
used spark plasma sintering to create a novel biodegradable
metal-matrix composite (MMC) with Zn as the matrix and hydrox-
yapatite (HA) as the reinforcement. Pure Zn powders and HA pow-
ders were mixed in a planetary ball mill under an argon
atmosphere for 1 h at 300 rpm. The mixed powders were then sin-
tered at 380 C and a pressure of 40 MPa for 6 min. The sinteredPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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ture consisting of HA particulates residing at the Zn boundaries.
Surface modification techniques have also been proposed to
improve the properties of biodegradable Zn further. Shomali
et al. [129] investigated the corrosion properties and biocompati-
bility of a poly(L-lactic acid) (PLLA)-coated Zn. The coating was
applied by a simple dip coating method, and coating thickness
was controlled by adjusting withdrawal speed and PLLA concentra-
tion. Jablonska et al. [97] confirmed the reduction of the corrosion
rate of Zn after a surface pre-treatment that involved immersion of
the metal in simulated body fluid (SBF) for a prolonged period.
Recently, additive manufacturing (AM) has been attracting a lot
of attention and is considered a viable option for manufacturing
metallic biomaterials [130]. This technique is especially useful for
creating net-shape or near-net-shape components, rapid prototyp-
ing, and for constructing one-off, customized implants that can
address specific patient needs. For 3-D printing metallic biomateri-
als, two of the most popular techniques are the powder bed fusion
(e.g., selective laser sintering (SLS) and selective laser melting
(SLM)) and direct energy deposition [131,132].
The prospects for the use of AM techniques in fabricating
biodegradable Zn [77,79,80,133,134] and Zn alloys (e.g., Zn-Mg)
[78] appears promising. Selective laser melting (SLM), which is a
type of AM process that produces metal parts by the fusion of pow-
ders using high power lasers, has been identified as a viable tech-
nique. Montani et al. [133] studied the processability of
biodegradable Fe and Zn by SLM. They produced Zn parts with a
relatively poor density of 88%, which they attributed to unstable
laser energy caused by the attenuation of the beam by evaporated
metal particles in the forming chamber. Further attempts to
improve part densities were later performed in several studies.
Demir et al. [77] adopted an open-air chamber instead of a closed
one and, after optimizing several process conditions, reported on
achieving 99% part densities. Likewise, Wen et al. [79,80] opti-
mized the SLM processing parameters and created part densities
of about 99.9%. They also noted how part porosity resulted from
either (i) lack of fusion due to inadequate laser energy or (ii) via
gas entrapment caused by excessive metal evaporation. Yang
et al. [78] used a stockfeed of Zn and Mg powders to successfully
fabricate biodegradable and biocompatible Zn-Mg alloys using
SLM. Finally, Grasso et al. [134] studied the feasibility of using
the plume characteristics of Zn for in-process monitoring to
improve the quality of the SLM product. They proposed an auto-
mated rule that allows the extraction of pertinent information
from captured video images that will be useful for monitoring
purposes.
Reports on the application of different fabrication techniques to
create actual Zn stents are also available and will be discussed in
Section 6.6.15. Mechanical properties of biodegradable zinc
Zinc is not renowned for its good mechanical properties. Zinc
has a lower yield and tensile strength compared to Mg or Fe. As
mentioned earlier, one of the issues raised against zinc, particularly
when used for cardiovascular stent applications, is its poor
strength. Materials for stents are required to have a tensile
strength of about 300 MPa, while pure Zn has a tensile strength
of about 28–120 MPa [21].
Cast pure Zn is not technologically useful since this exhibits
poor ductility (2–2.5%) at room temperature [135,136]. Zn assumes
the hexagonal close-packed (HCP) structure, which inherently
imparts poor ductility and toughness to the cast structure [137].
On the other hand, wrought pure Zn exhibits excellent ductility
with an elongation to failure of 60–80% (tested parallel to rollingying and fabrication techniques on the mechanical properties, biodegrad-
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crucial when manufacturing stents. Stents are typically small hol-
low tubes with typical diameters of about 2.5–3.0 mm [138] and
strut thickness of 70–175 mm [138,139]. Stent fabrication, there-
fore, requires that the metal is ductile enough to be drawn and
shaped to these specifications.
Various research have looked into ways to improve the
mechanical properties of biodegradable Zn. The most common
approach involves alloying Zn with different elements such as
Mg, Cu, and Li [21,23]. The influence of fabrication techniques on
the mechanical properties of Zn is also recognized by different
studies [87,92,94]. A natural consequence of strengthening a metal
is the reduction in ductility. This is where the excellent ductility of
wrought Zn becomes useful as it allows the possibility of strength-
ening without significant impairment of ductility and formability.
In this chapter, results of key studies done to improve the
mechanical properties of Zn are discussed. In particular, it focuses
on the influence of two primary factors; i.e., alloying and fabrica-
tion method. A final section presents some critical evaluation of
this topic.
Table 3 presents a catalogue of the reported mechanical proper-
ties of different biodegradable Zn and Zn alloys. This can give a
quick overview of the amount of work done to improve the prop-
erties of this material.
The most commonly reported mechanical properties are (i) ten-
sile properties, including yield strength, tensile strength, elastic
modulus, and ductility derived from the standard tensile test
(ASTM-E8 [140]); (ii) hardness, based on the Vickers hardness test
(ASTM E384-17 [141]); and (iii) compressive properties, such as
compressive yield strength and compressive elastic modulus,
obtained from the mechanical compression test (ASTM-E9 [142]).
Most of the tensile test specimens are often round or dog-bone-
shaped and machined from plates or billets. Furthermore, tensile
tests on Zn wires [102,107] and even microtubes [114] have also
been reported, though these tests are not common. One challenge
with tensile testing of wires is in gripping the specimen. Wires
have a thin profile and are easily damaged during gripping. Tensile
failures at the gripped section would often invalidate the results of
a test.
As mentioned previously and seen in Table 1, the desired prop-
erties for a candidate biodegradable metal is dictated by the target
medical application. Hence, future developmental work on Zn
should use these set of properties as its starting framework
[143,144]. It may also be suitable to use an Ashby-style materials
selection chart as suggested by Bowen et al. [145], as this allows
one to visualize two mechanical requirements simultaneously in
a single chart. Ashby charts will also be used in the current work
when appropriate.
5.1. Influence of alloying elements
Alloying refers to the process of adding impurities to enhance
the properties of a metal. Alloying alters the properties of the host
metal by inducing a change in the microstructure and triggering an
attendant strengthening mechanism. For example, impurities that
are dissolved in a single-phase microstructure cause solid solution
strengthening; while alloying elements that create a second phase
precipitate cause precipitation hardening [137]. For biodegradable
Zn, the mechanical properties of the alloy may be influenced by (i)
the type, (ii) the number, and (ii) the amount or concentration of
alloying elements, as seen in Table 3.
Fig. 2 shows an Ashby chart that compares the reported
mechanical properties (i.e., ductility or elongation to fracture, ef
vs. ultimate tensile strength, UTS) of different Zn compositions
including (i) pure, (ii) binary, (iii) ternary, and (iv) quaternary
alloys. The lines represent the target UTS (300 MPa) and ef (18%)Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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us understand the influence of alloying elements on the properties
of Zn.
At first glance, what stands out is that most of the work focused
on creating binary Zn alloys. Minimizing the number of alloying
elements is a logical approach since each addition of an alloying
element also increases expense and adds another layer of complex-
ity during fabrication. Another observation is that very few Zn
alloys, mainly extruded Zn-Mg binary alloys [94,101,102] and
some ternary alloys (i.e., Zn-Mg-Sr [115] and Zn-Mg-Mn [116],
have met the mechanical property standards set for cardiovascular
applications. The majority of the alloys did not meet both strength
and ductility requirement; while a fair amount of alloys have
exceeded the ductility requirements but did not achieve the neces-
sary strength. Even some of the commercial Zn alloys were lacking
strength but possesses outstanding ductility, as indicated in
Table 3. This shows the relative difficulty of producing Zn alloys
that meet the standard mechanical properties.
Another important conclusion taken from these observations is
that, from the point of view of enhancing mechanical properties,
there’s no strong justification for creating ternary and quaternary
alloys. The right combination of binary alloy composition and pro-
cessing may be enough to achieve the desired mechanical property
levels. Again, this conclusion is made from the point of view of
mechanical properties only. Considerable improvements in other
properties (e.g., biocorrosion) may result from ternary or quater-
nary alloy combinations that will justify such practice.
Some general conclusions can be made from the tabulated
mechanical property values shown in Table 3. Firstly, the addition
of a new element, regardless of the type, increases the strength and
decreases the ductility of Zn. This implies that, as long as the fab-
rication route is identical, a binary Zn alloy (i.e., Zn-X) would be
stronger but less ductile than pure Zn regardless of the type of ele-
ment added. The same is true when a ternary alloy derivative (e.g.,
Zn-Mg-X) is compared to their base binary alloy (i.e., Zn-Mg). Sec-
ondly, increasing the amount of alloying element similarly
enhances the strength and reduces the ductility of Zn. However,
there are exceptions such as those reported by Tang et al.[106],
where both strength and ductility of Zn-Cu alloy increased with
increasing Cu content, or that of Sun et al. [112], where the
strength decreased while ductility increased in Zn-Mn alloys with
increasing Mn content. These will be examined further in the suc-
ceeding discussions.
Fig. 3(a) and (b) show the tensile strength and ductility as a
function of alloying element composition (%) for various binary
Zn alloys (i.e., Mg, Ca, Sr, Cu, Ag, Al, and Mn), respectively. This
comparison is made between alloys formed via one type of manu-
facturing technique (i.e., extrusion including the variant hot iso-
static extrusion) only to eliminate the influence of fabrication
method.
Fig. 3 gives a clear indication of the influence of the type of
alloying element on the mechanical properties of Zn. For example,
at 1% composition, the strength and ductility of the Zn alloy varied
depending on the alloying element (i.e., Mg, Sr, Ca, Al, Cu). Magne-
sium, which is also the most common alloy addition to biodegrad-
able Zn, had the highest impact on enhancing the mechanical
strength of the Zn alloy. Copper, Ag and Sr additions also yielded
alloys that are relatively strong. However, only the Zn-Mg alloys
were able to meet the tensile strength of at least 300 MPa neces-
sary for implant applications. In contrast, very few of the Zn-Mg
alloys met the required ductility of 18%; while a number of the
other binary alloys displayed outstanding ductility including Zn-
Mn, Zn-Cu, Zn-Ag, and Zn-Al. Considering both tensile property
requirements, most of the alloys did not meet the set standard val-
ues except for the Zn-1.2Mg by Shen et al. [94], the Zn-0.8Mg by Jin
et al. [102], and the Zn-1Mg reported by Jarzebska et al. [101]. Thisying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
Table 3
Reported mechanical properties and in vitro biodegradability of Zn and Zn alloys.
Composition Fabrication Method Yield
strength,
MPa
Tensile
strength, MPa
Ductility,
%
In vitro corrosion
Physiological test
solution
Polarisation test CR, lm/yr (corrosion
current density, lA/cm2)
Immersion test CR, lm/yr
(immersion time, days)
Refs.
Pure
Zn (99.95%) Extrusion – 24 0.3 SBF (9.7) 62 (14) [19]
3 N Zn Casting – 20 0.3 SBF – 64 (14) [89]
4 N Zn Casting – – – Hank’s BSS 325 (5.5) – [70]
4 N Zn Casting 10 18 0.3 Hank’s BSS – – [87]
Hot-rolling 28 45 5.6 134 (9.1) 77 (56)
Extrusion 32 61 3.5 – –
4 N Zn Casting – 26 0 – – – [92]
Extrusion 130 180 54 – –
6 N Zn plate (likely wrought) – 35 9.4 Hank’s BSS – 11 (10)
13 (30)
[75]
6 N Zn tube Extrusion + Drawing – 44 7.6 – 28 (10)
37 (30)
Zn Casting 32 31 2.7 – – – [95]
4 N Zn Casting 23 30 3.3 Hank’s BSS 50 (3.5) 84 (30)
49 (90)
[116]
3 N Zn Commercial rods (likely
wrought)
– – – PBS 25 (test done after 3-day immersion) – [81]
Ringer’s 162 –
Whole blood 27 –
plasma 37 –
Zn (99.995%) Extrusion 51 111 60.0 Hank’s BSS 131 (9.0) 74 (14) [96]
4 N Zn Extrusion 52 96 7.6 – – – [55]
4 N Zn Extrusion 45 89 5.5 Hank’s BSS 27 (1.8) – [123]
Zn (ASTM B6-13, 99.990%) Hot-rolled 109 140 37.0 – – – [109]
4 N Zn Hot rolling – – – SBF 160 (11.0) – [108]
4 N Zn Extrusion + Drawing 86 116 50.0 – – – [107]
Zn (99.995%) Extrusion 55 111 64.0 Hank’s BSS (8.9) 77 (14) [110]
4 N Zn Extrusion 60 117 14.0 – – – [112]
Zn (99.995%) Extrusion 45 61 3.8 c-SBF – 22 (20) [106]
Zn (99.99%) Commercial rods (likely
wrought)
– – – r-SBF 90 60 (1) [146]
90 30 (7)
180 30 (14)
Zn (99.98%), 68% porosity Pressure infiltration
casting
5* – – c-SBF – 174+ (60) [127]
75% porosity 2* – – 110+(60)
3 N Zn Extruded 146* – – SBF 410 (14) – [126]
Spark Plasma Sinter
(Coarse powder)
43* – – 610 –
SPS (Fine powder) 31* – – 750 –
Zn (99.7%) Powder Metallurgy (PM) 33* 16* Hank’s BSS 2710 (138) [113]
Zn (98.7%) SLM 122 138 8.1 – – – [80
79]
3 N Zn SLM 43 61 1.7 SBF – 180 (28) [78]
Binary
Zn-Mg
Zn-1 Mg Extrusion 90 155 1.8 SBF (1.2) 70 (14) [19]
Zn-1.5 Mg Extrusion – 150 0.5 (8.8) 63
Zn-3 Mg Extrusion – 32 0.2 (7.4) 70
Zn-1 Mg Casting – 153 1.5 SBF – 53 (14) [89]
Zn-1.5 Mg Casting – 147 0.4 – 58
Zn-3 Mg Casting – 28 0.2 – 52
(continued on next page)
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Table 3 (continued)
Composition Fabrication Method Yield
strength,
MPa
Tensile
strength, MPa
Ductility,
%
In vitro corrosion
Physiological test
solution
Polarisation test CR, lm/yr (corrosion
current density, lA/cm2)
Immersion test CR, lm/yr
(immersion time, days)
Refs.
Zn-1 Mg Casting 88** – – 3.5 wt% NaCl (19.1) – [91]
Zn-2 Mg Casting 143** – – (49.0) –
Zn-3 Mg Casting 165** – – (8.8) –
Zn-5 Mg Casting 250** – – (21.4) –
Zn-1 Mg Casting 92 138 0.5 SBF (Kokubo) – 280 (7) [92]
Zn-1 Mg Extrusion 182 255 11.5 – 120
Zn-1 Mg Casting 128 185 1.8 Hank’s BSS – – [87]
Zn-1 Mg Hot-rolling 181 253 11.8 76.9 (10.8) 83 (56)
Zn-1 Mg Extrusion 205 266 8.4 – –
Zn-0.5 Mg Casting 67 134 4.8 – – – [95]
Zn-1 Mg Casting 74 143 3.3 – –
Zn-2 Mg Casting 96 154 2.2 – –
Zn-5 Mg Casting 101 – – – –
Zn-7 Mg Casting 106 – – – –
Zn-0.15 Mg Extrusion 114 250 22.0 Hank’s BSS 162 (11.0) 79 (14) [96]
Zn-0.5 Mg Extrusion 159 297 13.0 162 (11.0) 81
Zn-1 Mg Extrusion 180 340 6.0 166 (11.3) 83
Zn-3 Mg Extrusion 291 399 1.0 125 (8.6) 76
Zn-0.8 Mg Extrusion 203 301 14.7 Ion extract from
DMEM and MEM
– 69 (1) [55]
Zn-1.2 Mg Casting 117 130 1.4 Hank’s BSS 120 (7.7) 80 (30)
70 (90)
[94]
Zn-1.2 Mg Extrusion 220 363 21.3 190 (12.4) 110 (30)
90 (90)
Zn-3 Mg Casting 65 84 1.3 – – [98]
Homogenized 36 46 2.1 SBF (Kokubo) 300 (3.4) 250 (21)
1-ECAP 137 153 4.6 240 (2.7) 180
2-ECAP 205 220 6.3 280 (3.2) 190
Zn-1 Mg Cast – 120 0.4 – – – [101]
Zn-1 Mg Hydrostatic Extrusion 316 435 35.0 – –
Zn-1.6 Mg Extrusion 232 367 4.2 – –
Zn-0.05 Mg Indirect Extrusion 160 225 26.0 SBF 728 150 (14) [103]
Zn-0.002 Mg Ext + Drawing 34 63 17.0 – – – [102]
Zn-0.05 Mg Ext + Drawing 93 202 28.0 – –
Zn-0.08 Mg Ext + Drawing 221 339 40.0 – –
Zn-0.02 Mg Extrusion 136 167 27.0 – – – [105]
Ext + Drawing 388 455 5.4 – –
Zn-1 Mg SLM 74 126 3.6 SBF – 140 (28) [78]
Zn-2 Mg SLM 117 162 4.1 – 130
Zn-3 Mg SLM 152 222 7.2 – 100
Zn-4 Mg SLM 132 166 3.1 – 110
Zn-Ca
Zn-1Ca Cast 119 165 2.1 Hank’s BSS – – [87]
Zn-1Ca Hot-rolling 196 242 12.6 160 (10.8) 88 (56)
Zn-1Ca Extrusion 200 241 7.7 – –
Zn-Sr
Zn-1Sr Cast 120 171 2.0 Hank’s BSS – – [87]
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Table 3 (continued)
Composition Fabrication Method Yield
strength,
MPa
Tensile
strength, MPa
Ductility,
%
In vitro corrosion
Physiological test
solution
Polarisation test CR, lm/yr (corrosion
current density, lA/cm2)
Immersion test CR, lm/yr
(immersion time, days)
Refs.
Zn-1Sr Hot-rolling 179 218 19.7 174 (11.8) 95 (56)
Zn-1Sr Extrusion 216 264 10.6 – –
Zn-Cu
Zn-4Cu Extrusion 250 270 51.0 Hank’s BSS (4.1) 9.1 (20) [66]
Zn-1Cu Extrusion 149 186 21.0 c-SBF – 33 (20) [106]
Zn-2Cu Extrusion 200 240 46.8 – 27
Zn-3Cu Extrusion 214 257 47.2 – 30
Zn-4Cu Extrusion 227 270 50.6 – 25.5
Zn-3Cu Extrusion 214 257 47.2 Hank’s BSS 6 (0.4) 11 (20) [117]
Zn-3Cu Extrusion 247 288 45.9 SBF 85 (5.8) 45 (20) [120]
Zn-3Cu, 68% porosity PIC 11* – – c-SBF – 975+ (60) [127]
75% porosity 6* – – 780+(60)
Zn-Li
Zn-0.1Li Ext + Drawing 238 274 17.0 – – – [107]
Zn-2Li Hot-rolling 241 367 14.0 SBF 60 (4.0) – [108]
Zn-4Li Hot-rolling 428 446 13.8 50 (3.8) –
Zn-6Li Hot-rolling 478 569 2.4 – –
Zn-Ag
Zn-2.5Ag Extrusion 147 203 34.0 Hank’s BSS (9.2) 79 (14) [110]
Zn-5Ag Extrusion 207 252 36.0 (9.7) 81
Zn-7Ag Extrusion 236 287 32.0 (9.9) 84
Zn-Al
Zn-0.5Al Extrusion 119 203 33.0 Hank’s BSS 140 (9.6) 79 (14) [96]
Zn-1Al Extrusion 134 223 24.0 141 (9.7) 78
Zn-1Al Hot-rolling 197 238 24.0 – – – [109]
Zn-3Al Hot-rolling 202 223 31.0 – –
Zn-5Al Hot-rolling 240 308 16.0 – –
Zn-0.5Al Cast – 79 1.5 SBF (Kokubo) (20.4) 250 (10)
150 (30)
[118]
Zn-Mn
Zn-0.2Mn Extrusion 132 220 48.0 – – – [112]
Zn-0.4Mn Extrusion 118 200 54.0 – –
Zn-0.6Mn Extrusion 118 182 71.0 – –
Zn-4Mn Powder Metallurgy – 290.8* 14.9* Hank’s BSS 720 (48) – [113]
Zn-24Mn PM – 132.4* 6.7* 20 (2.1) –
Ternary
Zn-Mg-Ca
Zn-1 Mg-1Ca Casting 80 131 1.0 Hank’s BSS 170 90 (56) [88]
Hot rolling 135 194 8.5
Extrusion 205 257 5.3 113
Zn-Mg-Sr
Zn-1 Mg-0.1Sr Casting 109 133 1.4 Hank’s BSS 7.9 (0.12) – [115]
Zn-1 Mg-0.5Sr Casting 129 144 1.1 7.8 (0.11) –
Zn-1 Mg-0.1Sr Hot rolling 197 300 22.5 10.2 (0.15) –
Zn-1 Mg-1Sr Casting 86 138 1.2 Hank’s BSS 177 94 (56) [88]
(continued on next page)
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Table 3 (continued)
Composition Fabrication Method Yield
strength,
MPa
Tensile
strength, MPa
Ductility,
%
In vitro corrosion
Physiological test
solution
Polarisation test CR, lm/yr (corrosion
current density, lA/cm2)
Immersion test CR, lm/yr
(immersion time, days)
Refs.
Hot rolling 137 198 9.7
Extrusion 201 253 7.4
Zn-Mg-Fe
Zn-5 Mg-1Fe Hollow Sinking 151–186 180–218 5–21 SBF – – [114]
Zn-5 Mg-1Fe Mandrel Drawing 176–187 223–231 22–26 – 62 (48)
Zn-5 Mg-1Fe Hot -rolled – – – – 40 (48)
Zn-Mg-Mn
Zn-1 Mg-0.1Mn Casting 114 131 1.1 Hank’s BSS 260 (17.2) 120 (30) [116]
50 (90)
Zn-1.5 Mg-0.1Mn Casting 114 121 0.8 140 (9.3) 90 (30)
59 (90)
Zn-1 Mg-0.1Mn Hot rolling 195 299 26.1 250 (16.8) 112 (30)
64 (90)
Zn-Ca-Sr
Zn-1Ca-1Sr Casting 85 141 1.1 Hank’s BSS 188 109 (56) [88]
Hot rolling 140 200 8.8
Extrusion 212 260 6.7
Zn-Cu-Mg
Zn-3Cu-0.1 Mg Extrusion 346 365 4.8 Hank’s BSS 18 (1.2) 22 (20) [117]
Zn-3Cu-0.5 Mg Extrusion 403 416 1.9 24 (1.6) 30
Zn-3Cu-1 Mg Extrusion 427 441 0.9 180 (12.4) 43
Zn-Al-Mg
Zn-0.5Al-0.1 Mg Cast – 87 1.6 SBF (Kokubo) (17.3) 200 (10)
130 (30)
[118]
Zn-0.5Al-0.3 Mg Cast – 93 1.7 (11.2) 180 (10)
110 (30)
Zn-0.5Al-0.5 Mg Cast – 102 2.1 (9.5) 120 (10)
80 (30)
Zn-Al-Cu
Zn-4Al-1Cu Extrusion 171 210 1.0 SBF (5.2) 70 (14) [19]
Zn-Cu-Fe
Zn-3Cu-0.5Fe Extrusion 231 284 32.7 SBF 105 (7.1) 64 (20) [120]
Zn-3Cu-1Fe Extrusion 221 272 19.6 130 (8.8) 69
Zn-Mn-Cu
Zn-0.75Mn-0.40Cu Casting 113 120 0.4 – – – [119]
Zn-0.35Mn-0.41Cu Casting 77 84 0.3 – –
Zn-0.75Mn-0.40Cu Hot rolling 196 277 15.3 SBF 62 (4.1) 50 (14)
Zn-0.35Mn-0.41Cu Hot rolling 198 292 29.6 98 (6.5) 65
Quaternary
Zn-Mg-Al-Bi
Zn-0.5Al-0.5Mg-0.1Bi Casting – 102 2.4 SBF (Kokubo) (12.1) 174 (7) [122]
Zn-0.5Al-0.5Mg-0.3Bi Casting – 108 2.7 (16.4) 203
Zn-0.5Al-0.5Mg-0.5Bi Casting – 98 2.0 (22.7) 283
Commercial
ZA4-1 (3.5–4.5Al, 0.75–1.25
Cu, 0.03–0.08Mg)
Extrusion 78 187 170 Hank’s BSS 47 (3.0) – [123]
ZA4-3 (3.5–4.3Al, 2.5–3.2Cu,
0.03–0.06Mg)
Extrusion 110 201 126 374 (7.2) –
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ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriaresult indicates that the optimum Mg content appears to be about
1 to 1.5 wt% and that a proper fabrication technique could yield the
desired mechanical properties. Copper (Cu) and silver (Ag) addi-
tions also produced alloys that are relatively strong and ductile
and could be promising alloys in the future.
Fig. 3 also show the effect of the amount of alloying element on
the mechanical properties of Zn. Except for a few cases, such as in
the Zn-Mn alloy, the strength increases while ductility decreases in
the Zn alloy with increasing alloying element concentration. The
case of Zn-Mg is interesting as some reported tensile strength to
be proportional with Mg content [55,95,96], while others reported
the opposite [19,89].
The dependence of mechanical properties on the type and
amount of alloying elements may be traced to how these factors
influence the inherent microstructures of these alloys. Alloying ele-
ments may affect the strength of the host metal through different
mechanisms depending on the type of microstructure created by
alloy addition. For example, for a solid solution, strengthening is
via the mechanism of solid solution strengthening; while for a
multi-phase alloy, enhancement is achieved by second phase
strengthening.
In solid solution strengthening, the degree of hardening
depends on the size, and therefore the type, of alloying elements
[137]. A considerable size difference between host and the impu-
rity atom (either substitutional or interstitial impurity atom)
induces higher lattice distortion and often leads to greater
strengthening. For second phase strengthening, the degree of
strengthening depends on the (i) characteristic, (ii) relative
amount, (iii) shape and (iv) distribution of the precipitate [137].
These parameters will again depend on the type and amount of
alloying elements, as well as in the kind of fabrication technique.
In most of the cited biodegradable Zn binary alloys, the
microstructure consists of multiphase systems. This means that
the mechanical properties of these alloys would depend primarily
on the characteristics of the second phase or precipitate. Levy et al.
[22] gave a good summary of the microstructures reported in dif-
ferent biodegradable Zn alloys; hence, an exhaustive list is not any-
more included in the current work. A thorough discussion of the
influence of multiphase microstructures on the mechanical proper-
ties of Zn alloys may not be any more necessary. However, two
cases will be cited herein to highlight the microstructure-
property relationship in Zn alloys. The first case is that of the Zn-
Mg alloy, which is the most studied Zn alloy and whose behaviour
is representative of the other binary alloys. The second one is the
Zn-Mn alloy, which exhibited an abnormal trend concerning the
relationship between mechanical properties and alloy
concentration.
Fig. 4 shows the phase diagram of the Zn-Mg alloy [102]. Most
of the reported biodegradable Zn-Mg alloys have Mg contents of
less than 10%. The phase diagram indicates that in this composition
range, a Zn-Mg solid solution (a-Zn) occurs at Mg wt% < 0.008%
and a multiphase system consisting of a-Zn and Mg2Zn11 at Mg
wt% > 0.008%. However, note that such applies to a temperature
of about 200 C, and the solubility limit of 0.008% is expected to
decrease at lower temperatures. This implies that all of the
reported biodegradable Zn-Mg alloys are primarily multi-phase
comprising of a-Zn and Mg2Zn11. The intermetallic Mg2Zn11 is
believed to be very hard but brittle; hence, the mechanical proper-
ties of the Zn-Mg alloys are largely influenced by the relative
amount of this intermetallic. The amount of Mg2Zn11 is expected
to increase with increasing Mg content. It is then reasonable to also
expect an increase in strength and a decrease in ductility with
increasing amounts of Mg in the Zn alloy, consistent with pub-
lished results [19,87,92,96,102]. It needs to be mentioned that
the size and distribution of the Mg2Zn11 are equally important,
but these features are dependent on the fabrication method. Theying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
Fig. 2. Plot of elongation at fracture (%) vs UTS as a function of the number of
alloying elements in Zn. Plotted values were obtained from appropriate references
listed in Table 3. Superimposed lines represent the nominal standard values
required for materials used for cardiovascular and orthopedic medical applications.
The coloured region represents the space of acceptable properties.
14 J. Venezuela, M.S. Dargusch / Acta Biomaterialia xxx (xxxx) xxxinfluence of fabrication technique on microstructure will be dis-
cussed in the succeeding section.
For the Zn-Mn alloy, Sun et al. [112] reported that the alloy’s
mechanical strength decreased and ductility increased withFig. 3. The plot of (a) tensile strength and (b) elongation at fracture (%) versus alloying e
values were obtained from appropriate references listed in Table 3.
Fig. 4. The Zn-Mg phase diagram at (a) 80–100 wt% Zn and magn
Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriaincreasing alloy content (i.e., 0.2, 0.4, and 0.6 wt% Mn), contrary
to what was typically seen in other biodegradable Zn alloys. They
noted that increased Mn additions significantly refined the Zn
grains and also increased the presence of the intermetallic,
MnZn13. Both of these microstructural changes should have
improved the strength of the alloy. However, they also noted a
decrease in the number of tensile twins with increasing Mn con-
tent. They then concluded that this decrease in twin defect played
a significant role in reducing strength and created the observed
anomalous mechanical behaviour of the metal. This proves that
while hard precipitates are expected to enhance strength, a combi-
nation of other microstructural features can still influence the
mechanical properties of the alloy.
Alloying appears to be similarly effective in improving the
mechanical strength of porous Zn constructs. For example, Hou
et al. [127] noted that adding Cu improved the compressive
strength of porous Zn, even at 68% and 75% porosity volumes.5.2. Influence of fabrication technique
An important concept in the field of materials science is the
interrelationship between processing, microstructure, and proper-
ties. Different fabrication techniques create different microstruc-
tures with varying properties. Therefore, the idea of controlling
material property by adopting different fabrication techniques is
reasonable and has already been implemented in different metallic
systems.lement concentration (%) for different binary Zn alloys formed via extrusion. Plotted
ified at (b) 99.8–100 wt% Zn (Adopted from Jin et al. [102]).
ying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
J. Venezuela, M.S. Dargusch / Acta Biomaterialia xxx (xxxx) xxx 15Fig. 5a and b show a plot of tensile strength vs. alloying element
concentration and elongation to fracture (%) vs. alloying element
concentration, respectively, of different Zn-Mg alloys as a function
of various fabrication techniques. The reported methods include
the traditional metal forming processes such as casting, extrusion,
drawing, and hot rolling, as well as some of the advanced tech-
niques such as cold hydrostatic extrusion, ECAP, and SLM. Other
binary alloys of Zn are deliberately excluded from the plot. This
allows a direct comparison between techniques by removing the
influence of the type of alloying elements.
Fig. 5 clearly indicates that the products of the wrought tech-
niques (i.e., extrusion, drawing, rolling) exhibit a better combina-
tion of mechanical properties (i.e., higher strength and better
ductility) than cast products. This may be seen by comparing the
strength and ductility of the Zn-Mg alloy at specific compositions
(e.g., 1%). The extruded Zn and Zn alloys possessed the highest
strength, followed by the rolled products, then the as-cast ones
[88]. The benefits of a combined extrusion and drawing process,
as well as the advanced wrought processing, are also evident. For
example, the combined extrusion and drawing process [102] and
the cold hydrostatic extrusion [101] yielded products with the best
combination of properties among the Zn-Mg alloys; i.e., relatively
high strength and high ductility. ECAP [98], another advanced
wrought process, was also seen to improve both strength and duc-
tility of the cast Zn-3Mg. In terms of ductility, wrought products
generally exhibited the highest ductility; while their cast counter-
parts possessed the lowest ductility. Jin et al. [102] reported that a
combination of extrusion and drawing, coupled with microalloy-
ing, is especially effective in significantly enhancing both the
strength and ductility of the Zn alloy. In contrast, Wang et al.
[105] noted that the strength increased but ductility decreased
after drawing (cumulative reduction in area of 97%) of an extruded
Zn-0.02Mg alloy. It is also noteworthy to mention that only the
extrusion and the extrusion + drawing process yielded Zn products
that have sufficient strength and ductility to meet the nominal
mechanical property standards.
Fig. 5 yields some important considerations. It gives clear evi-
dence on the influence of processing technique on the resulting
mechanical properties of Zn and Zn alloys, and the evident advan-
tages of using wrought Zn products in future implants. This is con-
sistent with the well-known superiority of wrought Zn products
over their as-cast counterparts [135,136]. The mechanical weak-
ness of the cast Zn-Mg alloy may be linked to several factors: (i)
the HCP crystal structure that makes Zn inherently poor in ductil-
ity, (ii) the presence of relatively coarse-grained microstructureFig. 5. The plot of (a) tensile strength and (b) elongation at fracture (%) versus alloyi
fabrication techniques. Plotted values were obtained from appropriate references listed
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ing of the metal, (iii) casting defects such as porosity, voids, inclu-
sions, even micro- and macrosegregation, and (iv) the presence of
brittle, second phase precipitates (e.g., Mg2Zn11). It appears that Zn
has a propensity to form brittle intermetallics not only when
alloyed with Mg, but also with other elements such as Ca, Sr, Al,
Cu, Li, and Ag [22]. The presence of intermetallic precipitates is
of critical importance as it can strongly influence the mechanical
properties strength of the host metal in two ways. Intermetallic
precipitates can either cause weakening, when these are coarse
and distributed non-uniformly; or strengthening when these are
fine and distributed uniformly in the host metal.
On the other hand, Dambatta et al. [99] showed that homoge-
nization of cast Zn could be beneficial. This additional heat treat-
ment improves ductility by relieving stresses, reducing defects,
and improving compositional uniformity in the as-cast structure.
Homogenization also increases the elongation at fracture but low-
ers the alloy’s strength due to larger grain sizes [96,99]. Vida et al.
[100] fabricated cast Zn-Mg (Zn-0.3%Mg and Zn-0.5%Mg) alloys via
a directional solidification process. They observed different
microstructures, such as columnar, columnar/dendritic, and
equiaxed, formed along the length of the cast alloy due to the dif-
ferent rates of cooling present during the solidification step. While
they did not report on the mechanical properties of the cast Zn pro-
duct, it would be logical to conclude that these different combina-
tions of microstructures would possess a range of mechanical
properties.
Though lower strength and elongation properties are intrinsic
to as-cast Zn alloys [19], the mechanical properties of Zn-Mg alloys
are improved by employing thermal wrought processes such as hot
extrusion [55,87,92,94,96] or hot rolling [87]. Wrought processing
is known to alter the microstructure of the feed metal effectively.
The occurrence of recovery and recrystallization during hot work-
ing determines the final microstructure and the attendant good
mechanical properties of the Zn alloy. Hot working especially
improves the elongation properties [55,87,92,94] by redistributing
the brittle phase particles [65], dynamically recrystallizing the Zn
grains [55,96], refining grain sizes [92,94,96] and reducing the vol-
ume fraction of the eutectic mixture [94]. The combination of hot
extrusion followed by cold drawing is also expected to improve
the strength of Zn [137,147]. Cold working will increase the dislo-
cation density in the hot-worked microstructure and strengthening
via the strain hardening mechanism [147].
Powder metallurgy (P/M) appears to be a viable process for
forming Zn. The powder process can be used for fabricating (i) fullyng element concentration (%) of biodegradable Zn-Mg alloys formed via different
in Table 3.
ying and fabrication techniques on the mechanical properties, biodegrad-
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[126], and even (iii) metal-matrix composites (MMC) [128]. Porous
Zn can also be created using NaCl as a space holder [127]. However,
when adopting these techniques, the user needs to recognize the
adverse influence of porosities on the mechanical properties of
its products. Additionally, Capek et al. [126] observed that sintered
Zn made of coarse powder exhibited better compressive properties
than those made of fine powder due to a lower volume of porosity.
Hou et al. [127] noted that increasing porosity content lowers the
compressive strength of both Zn and Zn-3Cu, as seen in Table 3.
This is consistent with other reports that describe the negative
influence of porosity on the mechanical properties of 3D printed
Zn [79,80]. The fact that compressive tests are more appropriate
for testing porous Zn is a good indication of the adverse effects
of porosity on the tensile properties of a material. This behaviour
limits the applicability of porous Zn to those applications where
compressive properties are more important, such as in some ortho-
pedic applications (e.g., dental medicine) [148].
Yang et al. [128] was one of the first to report on the mechanical
properties of a biodegradable Zn-hydroxyapatite (Zn-xHA, x = 1.5–
10 wt%) MMC. This combination would be particularly useful for
orthopedic applications since hydroxyapatite is a known bioactive
ceramic [149]. They observed that increasing amounts of HA had
no influence on compressive yield strength and microhardness,
but significantly reduced the ultimate compressive strength of
the composite. Though no explanation was offered for the observed
weakening, it is possible that this could be attributed to poor inter-
face adhesion between the two materials.
It will be interesting how the mechanical properties of additive-
manufactured biodegradable Zn evolve in the future. 3-D printed
metal products often experience much higher cooling rates during
solidification compared to the cast metal. This means that the 3-D
printed product will have a finer microstructure and is expected to
be stronger than a cast product. Indeed, Wen et al. [79] created 3-D
printed pure Zn with generally better mechanical properties than
its cast and even some of its extruded counterparts, as seen in
Table 3. Likewise, Yang et al. [78] reported that the SLM-
manufactured Zn-3Mg alloy exhibited better mechanical proper-
ties (i.e., YS, UTS and % ductility of 152 MPa, 222 MPa, and 7.2%,
respectively) than the cast alloy. However, this set of mechanical
properties is still inadequate to meet the nominal standards. One
particular issue with 3-D printed metals is the presence of porosi-
ties, which adversely affect both the strength and ductility of the
product [79,133]. This and other issues will have to be addressed
in future research to improve the feasibility of 3-D printed Zn parts
in implant applications.
5.3. Critical evaluation
What is evident from the above-cited works is the certainty of
manipulating the mechanical properties of Zn to the desired level
via several approaches, specifically by altering the chemical com-
position or by adopting the appropriate fabrication technique.
The collated literature suggest that the Zn-Mg alloy coupled
with an appropriate wrought processing technique (i.e., extrusion,
hydrostatic extrusion, drawing) offers the best combination of
mechanical strength, ductility, and formability. The recommended
alloy composition range would be less than 1.5% Mg. Beyond this
composition, the alloys gain strength but significantly loses ductil-
ity due to the increase in the hard but brittle phase, Mg2Zn11. Some
of the microalloyed Zn-Mg alloys appeared to be equally promis-
ing, such as the extruded and drawn Zn-0.08Mg [102] and Zn-
0.02Mg [105]. It is also worthwhile to consider pursuing future
studies on cold hydrostatic extrusion as initial results indicate its
capability to produce products with desirable mechanical
properties.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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to fabricating Zn with properties that meet the nominal standard,
it is likely that future research will be successful in finding the cor-
rect alloy composition and fabrication technique that will yield the
desired product. However, it would also be beneficial if future
endeavours are geared toward addressing several important issues
with regard to understanding the mechanical behaviour of Zn.
Firstly, it is essential to identify the mechanical properties that
are most relevant to a corresponding medical application. For
example, many studies report on the alloys’ tensile strength
together with hardness data. For most metals, hardness is propor-
tional to tensile strength. This means that the hardness results are
redundant when tensile values are already cited, and the resources
used in doing this test could have been used for a more relevant
one. Also, related to the issue of identifying application-specific
properties, it was observed that most studies intending to use Zn
for stent applications did not measure the radial strength of Zn.
For stents, radial strength is reasonably crucial to measure as this
parameter directly relates to the mechanical behaviour of hollow
tubes. It is clear that by establishing a hierarchy of critical param-
eters for specific applications (e.g., for stents, important properties
may include tensile strength, ductility, fatigue, collapse pressure,
and tube radial strength) then results of studies become more rel-
evant and project resources are more efficiently utilized.
Secondly, the accurate figure of merit for these identified prop-
erties needs to be ascertained. For example, for cardiovascular
stent applications, candidate metallic materials are required to
possess a minimum tensile strength of 300 MPa and a minimum
ductility of 18%. It appears that these values were adopted from
specifications imposed on stainless steel (SS) stents. However,
most of the commercially-available, bioabsorbable polymeric
stents have mechanical property values that are significantly lower
than the mentioned standard. For example, Abbott’s Absorb BVS
and Amaranth’s Fortitude Aptitude stents are both made of poly-
L-lactic acid (PLLA), which has a tensile strength of about 60–
70 MPa and a % elongation at break of about 2–6% [139]. Even some
of the proposed bio-corrodible metal-based stents use metals with
properties that barely exceed the standard. For example, Biotro-
nik’s DREAMS 2G and Envison Scientific’s BIOLUTE-next uses the
WE43 Mg alloy that has a tensile strength of 220–330 MPa and %
elongation at break of 2–20% [139]. Furthermore, Yang et al. [86]
reported that a pure Zn stent is indeed viable as it was able to hold
mechanical integrity for at least 6 months in vivo. From these
cases, it is clear that the current nominal standard needs to be
re-evaluated. A more relevant and accurate figure of merit for a
specified property would undoubtedly lead to better screening
and selection of future biomaterial prospects.
Finally, the issue of age-hardening and strain-rate sensitivity in
Zn alloys needs to be studied and resolved. Jin et al. [102] reported
on the age hardening of the Zn-0.08Mg alloy, where the tensile
strength increased from 266 to 498 MPa and ductility decreased
from 29.8 to 12.7% after room-temperature aging of 9 days (tested
at a strain rate of 3.30  103). After 12 months, the tensile
strength was measured at 434 MPa and ductility at 3.5%. While
the increase in strength is attractive, the significant drop in ductil-
ity is objectionable. This instability in mechanical properties with
aging time is alarming and can severely limit the applicability of
the biodegradable Zn alloy. Jin et al. also noted that the mechanical
properties of the microalloyed Zn were strain-rate sensitive. For
example, by increasing the strain rate from 1.67  104 s1 to
1.67  102 s1, the tensile strength of Zn-0.8Mg increased from
227 MPa to 614 MPa and ductility decreased from 92.3% to 2.3%.
The strain-rate sensitivity of Zn alloys is important to assess as this
will define not only the applicability of the alloy but also the
proper fabrication technique for shaping the metal. It is also possi-
ble that these two phenomena occur just for some of the Zn alloys.ying and fabrication techniques on the mechanical properties, biodegrad-
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to be ascertained and its impact on service performance be
assessed before a candidate Zn alloy is endorsed for commercial
use.6. Biodegradation and biocompatibility of zinc
Biodegradation or biocorrosion refers to the decomposition of a
material by the action of living organisms such as bacteria and
microbes, or by other biological means such as being inside the
human body. While the definition of biodegradation is reasonably
straightforward, biocompatibility is a broad and complex term.
Several definitions have already been proposed, yet no single def-
inition encompasses what biocompatibility implies. Biocompatibil-
ity can describe the property of a material to exist harmoniously
with living tissues without causing serious harm or deleterious
changes to the living host. On the other hand, some proposed that
biocompatibility should also include the ability of the material to
perform its desired therapeutic function without eliciting any
undesirable side effect to its host [150]. Williams [150] suggested
that the key to understanding biocompatibility is to determine
which chemical, biochemical, physiological, physical or other
mechanisms become operative at the physiological conditions
associated with the contact between the biomaterial and the tis-
sues of the body, and then assess the consequences of such
interactions.
In this section, the biodegradation and biocompatibility of Zn
and Zn alloys will be discussed. The section starts with a descrip-
tion of the different techniques to assess biodegradability and bio-
compatibility, followed by a discussion of the corrosion
mechanism for Zn in a physiological environment. The succeeding
chapters will cover in vitro corrosion behaviour, in vitro biocom-
patibility, and in vivo performance of biodegradable Zn.6.1. Assessment of biocorrosion and biocompatibility
Both biodegradability and biocompatibility are of primary
importance when assessing the properties of a candidate implant
material. Both properties may be evaluated in vitro or in vivo.
The term in vitro literally means ‘in glass’. An in vitro test, there-
fore, means that the test is conducted away from the usual biolog-
ical surrounding. When assessing a candidate implant material,
this means that the test is conducted outside of the human body.
The term in vivo means ‘within the living’. Hence, an in vivo test
implies that the test is done within its natural biological setting;
and in an implant’s case, within an animal or the human body.
In vitro biocorrosion testing involves several techniques, with
two of the most common being (i) electrochemical polarisation
tests and (ii) immersion test. It needs to be mentioned that each
method possesses salient features and applicability, hence the
need for prudence when using and interpreting results from a par-
ticular technique. A review by Kirkland et al. [151] of the different
techniques to assess the corrosion of biodegradable Mg reveals the
shortcomings of users to understand the applicability each corro-
sion test, as well as a lack of control of experimental variables that
profoundly impact results and its interpretation.
Potentiodynamic polarisation experiments involve the classic
three-electrode apparatus consisting of a working electrode (the
tested metal), a reference electrode (e.g., standard calomel elec-
trode) and a counter electrode (e.g., platinum). Typically, the test
electrolyte is a fluid that mimics the physiological environment,
such as the balanced salt solutions (BSS) like Ringer’s (RBSS) and
Hanks’, phosphate-buffered saline (PBS) solution, and simulated
body fluid (SBF) [103]. In some degradation tests, actual human
plasma and whole blood were used [81]. A potential is applied toPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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scan is performed over a certain potential range and at a set scan
rate (e.g., 0.1667 mV/s). The test generates a plot of current versus
potential (IV curve), which is analyzed to yield important parame-
ters such as the corrosion potential (Ecorr) and corrosion current
density (icorr). The corrosion rate (CR) in mm yr1 may be deter-
mined according to ASTM G59-97 [152]:
CR ¼ 3:27 103 icorrEW
q
ð1Þ
where icorr (lA cm2) is the corrosion current density, EW (g eq1) is
the equivalent weight, and q (g cm3) is the density of the metal.
Another popular electrochemical test is the electrochemical
impedance spectroscopy (EIS) [153]. The EIS uses alternating cur-
rent (AC) polarisation versus direct current (DC) polarisation in
the traditional potentiodynamic test. Impedance, capacitance,
and resistance values are typically obtained from the test; and such
information can elucidate on the active corrosion mechanisms
when the metal is exposed to a specific environment. However,
EIS analysis often requires a mature and deep understanding of
the corrosion process to acquire accurate interpretations of test
results. Finally, EIS may also be used to estimate the rate of corro-
sion by using the polarisation resistance, Rp, and the Stern-Geary
relationship to get icorr [152]:
icorr ¼ babc2:303Rpðba þ bcÞ
ð2Þ
where ba and bc are the anodic and cathodic Tafel slopes. This value
of icorr may then be used to measure the corrosion rate, CR, accord-
ing to Eq. (1).
The immersion test, as the name implies, involves dipping or
immersing the test material in the corrosive environment, typically
in the physiological fluid, for a specified period. A common stan-
dard adopted for the immersion test is ASTM G31-72 [154]. The
reported immersion tests are typically done in static flow condi-
tions, with the test solution regularly replaced with a fresh one
after a certain immersion period. Regular replacement of the test
solution is important as the Zn corrosion process is found to
increase the pH of the bath [19], which in turn affects the rate of
corrosion of the tested metal. After the specified immersion inter-
val has elapsed, the specimen is taken out of the solution, cleaned
of corrosion products (following an appropriate standard, e.g.,
ASTM G1-03 [155]), and weighed. The corrosion rate, CR
(mm yr1), may be evaluated using the equation [154]:
CR ¼ K W
Atq
ð3Þ
where K is a constant, W (g) is the mass loss of the specimen, A
(cm2) is the surface area, t (h) is the time of exposure, and q
(g cm3) is the density.
Another way of estimating in vitro corrosion rate is by measur-
ing the amount of released metal ions in the cultivation medium of
a biocompatibility test. Kubasek et al. [55] proposed this
approached where they measured the amount of Zn ions present
in the DMEM (Dulbecco’s modified Eagle’s medium) and MEM
(minimum essential medium) extracts using ICP-MS (inductively
coupled plasma mass spectrometry).
When assessing biocompatibility, a good starting point is to
understand that there are a number of possible responses that a
living host elicits when it comes into contact with a biomaterial.
Williams [150] gave an exhaustive list of these responses, which
includes (i) generalised cytotoxic effects; (ii) protein adsorption
and desorption characteristics; (iii) fibroblast behaviour and fibro-
sis; (iv) specific cell responses such as osteoclasts and osteoblasts
for bone; (v) platelet adhesion, activation, aggregation; (vi)ying and fabrication techniques on the mechanical properties, biodegrad-
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(viii) genotoxicity, and (ix) tumor formation. Therefore, biocom-
patibility tests are similarly numerous and are used to qualitatively
and quantitatively assess these responses of the tissue to the new
material [156].
Some of the in vitro biocompatibility tests reported for
biodegradable Zn include testing for (i) cell viability or cytotoxicity
[66,70,78,93,94,103,106,117,118,123], (ii) cell proliferation
[55,87,157] (iii) cell adherence [92,157], (iv) hemolysis and hemo-
compatibility [70,75,87,94,116,123], (v) dynamic blood clotting
and platelet adhesion [70,94,116,123], (vi) enzymatic and hydroly-
tic degradation [76], (vii) inflammatory response [93], (viii) gene
expression profiles and genotoxicity [55,157], (ix) systemic toxicity
[103], and (x) antibacterial effect [66,106,118]. These tests are
often done in compliance with an established standard; e.g., ISO
10993-5 [158] is adopted to test in vitro cytotoxicity, ISO 10993-
11 [159] for testing systemic toxicity, and ASTM F-756-17 for
assessing hemocompatibility [160].
In vivo biodegradation and in vivo compatibility tests involve
the implantation of the biomaterial in a living host. For Zn, the
reported host animals include Sprague-Dawley rats
[18,72,74,102,107,109], C57BL/6 mice [87] and rabbits [86,103].
Implant location often depended on the intended application. For
example, for cardiovascular stent application, the Zn metal was
implanted in the abdominal aorta [18,74,102,108]; while for ortho-
pedic application, Zn was inserted in the bone [87,103]. A novel,
low-cost method for implanting wires was proposed by Pierson
et al. [60], and this was adopted in several studies
[18,74,102,108]. This involves puncturing the arterial wall with
the implant, directing a portion of the implant within the lumen,
and eventually redirecting the implant to puncture the wall a sec-
ond time to exteriorize the wire from the lumen. This allows a por-
tion of the wire to be exposed to flowing blood and simulating the
service condition of a stent. After some time, the implant is
removed and the explanted material is then assessed.
The corrosion rate of the implant may be measured by deter-
mining weight loss, as determined by equation (2). However,
Bowen et al. [161] suggested that this conventional method is
not appropriate for determining the corrosion rate of a specimen
with a high aspect ratio, such as a wire. They proposed that the cor-
rosion rate may be assessed by measuring the reduction in cross-
sectional area (CSA) over time of exposure. The corrosion penetra-
tion rate, P0, is then calculated using the equation [161]:
P
0 ¼
ﬃﬃﬃﬃ
Ao
p
q

ﬃﬃﬃ
At
p
q
t
ð4Þ
where Ao, is the nominal CSA, At is the instantaneous CSA at implan-
tation time, t.
Li et al. [87] proposed another technique for measuring in vivo
corrosion rate by using micro-CT imaging to measure changes in
implant volume. Corrosion rate, CR, is then estimated using the
equation:
CR ¼ V0  Vt
At
ð5Þ
where Vo, is the volume of the implant at week 0, Vt is the volume of
the implant at the designated implantation time interval, t, and A is
the initial implant surface area.
In vivo biocompatibility is determined by assessing the overall
health of the tissue mass surrounding the implant via histological
analysis. Cell proliferation, cell morphology, osseointegration,
antibacterial properties, and inflammatory response of the affected
tissues may be checked. Systemic toxicity, which refers to toxic
effects in a site distant from the implant location, may also be
determined. For example, viscera histology is conducted to checkPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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signs of the adverse side effects of degradation products, such as
infarctions, pathological changes, or corrosion product accumula-
tion [86,103].
6.2. Corrosion mechanism of Zn in a physiological environment
The environmental conditions that metals encounter inside the
body are relatively unique. It is therefore not surprising that the
corrosion behaviour of an implanted metal is different compared
to typical ambient or even saline corrosion performance. The char-
acteristics of this environment, from the corrosion-inducing aspect,
include [162]: (i) the presence of different salts in the blood, (ii) a
slightly elevated temperature of 37 C, (iii) an inherently neutral
pH that can change from acidic to basic depending on tissue
response to the implant, and (iv) a controlled amount of oxygen
that depends on which part of the body (e.g., bone vs. soft tissues)
the implant is attached.
Table 3 includes a list of the reported in vitro corrosion rate of
pure Zn in different physiological fluids. Though the scatter in
the reported corrosion rate of pure Zn may be high, what is clear
is that pure Zn definitely corrodes in a physiological environment,
as was observed in in vivo experiments [18].
Zheng et al. [9] proposed a generalized reaction to describe the
degradation of metals in the nearly neutral environment present
inside the human body. When applied to Zn, the oxidation and
cathodic reaction are as follows:
Zn! Znþ2 þ 2e ð6Þ
2H2Oþ O2 þ 4e ! OH ð7Þ
while the product formation reaction involves:
Znþ2 þ 2OH ! Zn OHð Þ2 ð8Þ
Znþ2 þ 2OH ! ZnOþH2O ð9Þ
It is believed that zincite (ZnO) is the more dominant corrosion
product than zinc hydroxide (Zn(OH)2) as it is the more thermody-
namically stable oxide in physiological conditions. On the other
hand, Zn(OH)2 can redissolve due to chloride attack:
Zn OHð Þ2 þ 2CI ! Znþ2 þ 2OH þ 2CI ð10Þ
and the released Zn ions can react with phosphate ions to form
insoluble Zn phosphate (or hopeite):
Znþ2 þ 2HPO42 þ 2OH þ 2H2O! Zn3 PO4ð Þ2  4 H2Oð Þ ð11Þ
This sequence of reactions highlights one of the advantages of
Zn over Mg; i.e., the absence of gas (e.g., hydrogen) generation dur-
ing biodegradation.
The above reactions show that, aside from Zn, different ele-
ments reside in the corrosion product including P, H, O, and Cl
[18,19,55,92,94,99,123]. The presence of Ca and C has also been
reported in the product layer, as zinc (calcium) phosphates, smith-
sonite or zinc carbonate (ZnCO3), or bicarbonates
[18,19,97,107,116,117,146]. A majority of these ions originate from
the physiological environment. Complex hydroxides, carbonates,
and phosphates of Zn were also observed, including hydrozincite
(Zn5(CO3)2(OH)6), simonkolleite (Zn5(OH)8Cl2H2O), skorpionite
(Ca3Zn2(PO4)2CO3(OH)) CaZn2(PO4)22H2O, Zn5(OH)8Cl2H2O,
KZnPO40.8H2O, and even girvasite (H2NaCa2Mg3(PO4)3(CO3)
(OH)24H2O) [82,104,107,126,163]. The presence of these com-
pounds can vary along the thickness of the corrosion film. For
example, different studies reported that the Zn-based corrosion
products (e.g., ZnO, Zn(OH)2, Zn3(PO4)2) are found close to the sub-ying and fabrication techniques on the mechanical properties, biodegrad-
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are located on the top surface of the corrosion layer [18,19,146].
More importantly, these corrosion compounds can alter the
characteristics of the product layer and consequently affect the
corrosion characteristic of the underlying Zn substrate. For exam-
ple, an insoluble, passive film like ZnHPO4 or Zn-based carbonates
(e.g., Zn5(CO3)2(OH)6) could protect the underlying Zn metal and
delay degradation [23]. Similarly, hydrozincite and simonkolleite
can form a protective layer and prevent further deterioration of
biodegradable Zn [104,164]. Improvements in the degradation
resistance of some Zn-Mg alloys was reported to be due to Mg-
containing corrosion products that acts as a corrosion barrier
[96]. In contrast, zincite enhances degradation by forming a gal-
vanic couple with Zn [165].
Alloying elements can alter the corrosion mechanism and, con-
sequently, the resulting corrosion product of Zn. This will be dis-
cussed in detail in the succeeding section. Furthermore, the
location of the implant can influence the type of predominant cor-
rosion layer formed on Zn. In silico tests conducted by Alves et al.
[85] showed that simonkolleite [Zn5Cl2(OH)8] predominates when
Zn is implanted in the bone-muscle interface and zincite (ZnO)
when implanted inside the bone. This is important as the nature
of the corrosion layer could also determine the biocompatibility
of the Zn implant [85].
Recently, Yang et al. [86] proposed a detailed mechanism for the
degradation of a Zn stent inside a living host. Previous works have
already proposed corrosion mechanisms derived from in vivo tests
of Zn [18] and Zn alloys [107], and Bowen et al. [18] were the ear-
liest to report on this subject. However, the implants used in these
tests have geometries (e.g., wires or metal strips) that are funda-
mentally different from the typical stent. Yang et al. were the first
to suggest a corrosion mechanism derived from an in vivo test
where the implanted Zn has the net shape of an actual stent. There-
fore, it can be stated that the conditions present during their tests
are the closest to an actual cardiovascular service condition.
Yang et al. noted that Zn corrosion undergoes several stages
that are coincident with artery remodelling and other biological
changes occurring in the physiological environment surrounding
the implant. Fig. 6 shows the evolution of the implant-tissue inter-
action over a period of 12 months. Fig. 7 gives a detailed schematic
of the development of the degradation mechanisms, the location of
the concomitant corrosion products, and the duration of the tem-
poral tissue/implant response sequence of inflammation, granula-
tion tissue development, and tissue remodelling.Fig. 6. Evolution of neointima growth on the zinc stent over a period o
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uously flowing blood in the artery. Under this condition, ZnO/Zn
(OH)2 is initially formed at the surface (Fig. 7a). Over time, this cor-
rosion oxide eventually transforms to the more stable Zn3(PO4)24
(H2O) (Fig. 7b). Due to dynamic blood flow, mass transfer reactions
are enhanced, and degradation products are removed faster
thereby exposing fresh metal surface. This results in uniform or
general corrosion of Zn at a relatively high rate.
Between one to three months, neointima forms on the implant
by a process called endothelialization. This lining prevents direct
contact between the metal and blood. Corrosion reactions are
now dependent on (i) the diffusion of water, oxygen, and physio-
logical ions through the pores of the neointima, and on (ii) the
pH, which is altered from near neutral to acidic conditions due to
tissue inflammation. Consequently, the degradation behaviour of
the implant is altered and is significantly reduced. During this per-
iod, the Zn phosphate layer dissolves and recedes (Fig. 7c) due to a
decrease in pH associated with tissue inflammation. More impor-
tantly, during the breakdown of the protective Zn phosphate film,
cracks appear in the film and become sites of localized corrosion.
This means that the corrosion mechanism shifts from general to
localized corrosion, creating pits on the implant surface. Bowen
et al. [18] had earlier reported on a similar transition in the corro-
sion mechanism at these exposure periods for Zn wires implanted
in rats.
At 6–12 months, arterial cells continue to thicken and cover the
implant. During this period, localized corrosion still dominates as
the primary degradation mode. Aggressive ions (e.g., Cl) are able
to penetrate and continuously react with Zn to form a porous, inner
corrosion layer. ZnO is generated and forms a cover on top of the
remaining Zn skeleton, and by this time, the Zn phosphate layer
has been completely dissolved (Fig. 7d). At 6 months, though
inflammation has been significantly reduced, pH in the inner layer
is kept relatively high due to the slow diffusion environment. This
increased pH level leads to the concentration and oversaturation of
Ca ions, which is abundant in body fluids, and phosphate ions. This
phenomenon induces the precipitation of calcium phosphate
phases in the inner layer on top of the ZnO film (Fig. 7d). It is
important to mention that the precipitation of calcium phosphate
has been reported in biodegradable (e.g., Fe, Mg) and permanent
metal implants (e.g., Ti, CoCr), and in both orthopedic and cardio-
vascular implants [9,18]. The presence of Zn ions in the region
can also induce the substitution of Zn in the calcium phosphate
phase. The formation of the precipitate often signals an advancedf 12 months. Reprinted from [86], with permission from Elsevier.
ying and fabrication techniques on the mechanical properties, biodegrad-
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Fig. 7. Schematic showing the evolution of the in vivo degradation mechanism of Zn. (a) and (b) describes degradation during the period of endothelialisation in the first
3 months, while (c) and (d) refers to corrosion reactions occurring during granulation and remodelling between 3 and 12 months after implantation. Reprinted from [86],
with permission from Elsevier.
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healing process. It is also interesting that the amount of calcium
phosphate formed in the corrosion layer depends on the type of
implant material. For Mg-based stents, calcium phosphate can
entirely replace the strut section, while for Zn, the calcium phos-
phate is only a few microns thick [86]. The presence of this dense,
compact corrosion layer on Zn was similarly noted by Bowen et al.
[18]. Such behaviour is attributed to Zn’s two-fold ability to form
soluble calcium phosphate and inhibit the phosphate layer’s fur-
ther growth [166].
6.3. In vitro biodegradability of Zn alloys
Table 3 includes some of the measured corrosion rates for
biodegradable Zn and Zn alloys obtained from two types of
in vitro test; i.e., polarisation and immersion test. In some of the
studies that employed polarisation tests, corrosion rate was
reported in terms of corrosion current density, and these values
are also included in the table.
While comparing in vitro biocorrosion rate results with in vivo
results is certainly inadvisable, comparing in vitro degradation
rates reported by different studies and obtained from different
experimental conditions is similarly debatable. Indeed, it is rare
even to find a conformity between the corrosion rates obtained
from polarisation and immersion tests done in a single study. A
quick scan of Table 3 reveals that the reported in vitro tests, pri-
marily polarisation and immersion, were done under varying test
conditions such as different physiological solutions and immersion
times. These test parameters, along with others such as scan rate,
gas exchange in the electrolyte, ratio of specimen surface area to
electrolyte volume, pH buffering techniques, and flow conditions,
can influence the corrosion behaviour of the tested specimen
[151,167]. Indeed, Bowen et al. [21], in their review, avoided the
direct comparison of in vitro corrosion rates gathered from dis-
parate methods declaring that doing so would be fallacious. They
further advised that in vitro tests can easily produce misleading
results, hence the need for great caution when adopting a method-
ology and interpreting results. Clearly, this is a direct consequence
of the absence of an appropriate test standard for assessing thePlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriain vitro corrosion behaviour of biodegradable metals. Though
efforts have been made to address this problem [168], still no such
standard test exists. Hence, in the ensuing discussions, comparison
of corrosion results between different studies will be avoided when
possible, and conclusions would only be derived from the results of
analogous works.
It would also be useful to cite a study that investigated the
influence of applied stress on the biodegradability and in vitro per-
formance of Zn in a physiological environment. Torne et al. [82]
studied the susceptibility of Zn to stress corrosion cracking (SCC)
in SBF and whole blood. SCC refers to the phenomenon of sudden
or early failure of materials subjected to a corrosive environment
[169]. SCC is critical to consider especially for implants that will
be subjected to high physiological loads (e.g., bone plates, screws),
and Mg is known to be susceptible to SCC [170]. Torne et al.
reported that Zn remained ductile and demonstrated limited sus-
ceptibility to SCC in the physiological fluids. There was no signifi-
cant reduction in UTS, though some reduction in time to failure
was noted (25% compared to reference) when Zn was in m-SBF.
The SCC performance of Zn in whole blood was even better than
in SBF. Torne et al. suggested that the low SCC susceptibility of
Zn is due to the formation of an organic surface film that protects
the corroding surface from crack formation and growth.
6.3.1. Influence of alloying
The reported values of in vitro degradation rate, as shown in
Table 3, indicates that the corrosion behaviour of a Zn alloy is
dependent on (i) the type and (ii) quantity (i.e., alloy concentra-
tion) of alloying element. The influence of these factors will be cov-
ered in the following discussions.
Unlike the influence of alloying elements on the mechanical
properties of metals (i.e., alloying elements generally increase the
strength and reduce ductility of the host metal), there is no defini-
tive trend with regard to the influence of the type of alloying ele-
ments on corrosion behaviour. It is interesting that even reports
on an individual element can be contradictory. For example, Kuba-
sek et al. [55] noted a decrease in corrosion rate after Mg addition
to cast Zn. This is favourable for maintaining post-operative load
bearing capacity. Yang et al. [78] observed similar improvementsying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
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Zn. However, Mostaed et al. [96] and Vojtech et al. [19] noted an
increase in corrosion rate with Mg addition in extruded Zn; while
Li et al. [87] and Alves et al. [104] reported the same in hot-rolled
and cast Zn, respectively. Reports on Mg addition in ternary Zn
alloys appear to follow the same conflicting trend. Tang et al.
[117] observed that the addition of Mg enhanced the corrosion rate
of extruded Zn-Cu, while Bakhsheshi-Rad et al. [122] noted the
opposite when Mg was added to cast Zn-Al. In these cases, it is
likely that the type of fabrication technique may have influenced
the reported results.
For binary Zn alloys, additions of Ca [87], Sr [87], Cu [106], Ag
[110], and Al [96] were all reported to enhance the degradation
rate of wrought Zn. In contrast, Li [108] was observed to reduce
the corrosion rate of hot-rolled Zn.
For ternary Zn alloys, Yue et al. [120] reported that the addition
of Fe enhanced the corrosion rate of biodegradable Zn-3Cu; while
for quaternary Zn alloys, Bakhsheshi-Rad et al. [122] noted that
Bi increased the corrosion rate of the ternary alloy Zn-0.5Al-0.5Mg.
Concerning the influence of alloying element concentration on
the degradation rate of Zn alloys, it appears that reports vary and
often the trend is dictated by the type of element added. For binary
Zn-Mg, the observed trends are somewhat conflicting. Mostaed
et al. [96] noted that the corrosion rate of the extruded Zn-xMg
(x = 0.15, 0.5, 1, 3) alloy increased as Mg content increased to 1%,
then decreased as Mg content increased to 3%. Interestingly, Voj-
tech et al. [19] also observed an increasing corrosion rate with
increasing Mg content for extruded Zn-xMg (x = 1, 1.5) when the
corrosion rate was derived from potentiodynamic polarisation
experiments (i.e., from corrosion current density); but the com-
plete opposite was observed from the results of the immersion
tests. In contrast, Yang et al. [78] only noticed a continuous reduc-
tion in degradation rate with an increasing amount of Mg in 3-D
printed (SLM) Zn-xMg (x = 1, 2, 3, 4), while Kubasek et al. [89]
reported comparable corrosion rates in cast Zn-xMg (x = 1, 1.5, 3)
with different Mg content.
In some Zn-Mg-based ternary alloys, increasing Mg content
reduced the corrosion rate of cast Zn-0.1Mn-xMg (x = 1, 1.5)
[116] and of cast Zn-0.5Al-xMg (x = 0.1, 0.3, 0.5)[122]; but
enhanced the degradation rate of extruded Zn-3Cu-xMg (x = 0.1,
0.5, 1) [117].
For other binary Zn alloys, increasing Cu content improved the
corrosion resistance of extruded Zn-xCu (x = 1, 2, 3, 4) alloy [106].
Increasing Ag content enhanced the degradation rate of extruded
Zn-xAg (x = 2.5, 5, 7) alloy [110], while increasing Al content had
negligible effect on the corrosion rate of extruded Zn-xAl (x = 0.5,
1) [96].
For some ternary Zn alloys, it was reported that increasing Sr
and Mn amounts led to a reduction in the corrosion rate of cast
Zn-1Mg-xSr (x = 0.1–0.5) [115] and hot-rolled Zn-0.40Cu-xMn
(x = 0.75, 0.35) [119], respectively. Increasing Sr content also
reduced the degradation rate of Zn–4Al–xSr (x = 0.03, 0.06, 0.1,
0.15) [121]. In contrast, increasing Fe enhanced the degradation
rate of extruded Zn-3Cu-xFe (x = 0.5, 1) [120].
Increasing Bi concentration increased the corrosion rate of the
cast quaternary alloy Zn-0.5Al-0.5Mg-xBi (x = 0.1, 0.3, 0.5) [122].
Wang et al. [123] confirmed a significant enhancement in degrada-
tion rate after an increase in Cu amounts in some commercial Zn
alloys (i.e., ZA4-1 versus ZA4-3). These alloys are quaternary Zn
alloys consisting of Zn, Al, Cu, and Mg. Kannan et al. [124] found
that Al temporarily improved the passivation behaviour of a com-
mercial biodegradable Zn-5Al-4Mg alloy. After extended periods of
immersion in SBF (i.e., >3 days), the alloy showed higher corrosion
rate than pure Zn.
Alloying can generally alter the corrosion behaviour of a metal
via several ways. However, while conclusions from studies on thePlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriamechanical behaviour of Zn alloys are fairly unanimous, the influ-
ence of alloy addition on the corrosion behaviour of Zn is arguably
more complicated and is difficult to predict. This is likely due to the
greater impact that microstructure and surface conditions hold on
corrosion behaviour compared to chemical composition. Further-
more, the corrosion regime, i.e., either localized or uniform, has a
significant impact on the corrosion products and resulting corro-
sion layer, and can consequently affect the degradation behaviour
of the metal [171].
One way by which an alloying element changes the corrosion
resistance is by causing a change in the inherent standard potential
of the host metal, as indicated by shifts in the open cell corrosion
potential to different values. This was cited for the increase in cor-
rosion rate in Zn after addition of Ca [87], Sr [87], or Al [96].
Another mode is by inducing a change in the microstructure
(e.g., from single to multi-phase system, change in grain size)
[169,172,173]. For biodegradable Zn, a majority of the reported
changes (i.e., increase or decrease in corrosion resistance) in its
degradation behaviour after alloying were traced to alterations to
its metallurgical structure. For example, the addition of an alloying
element to pure Zn frequently creates a multiphase system consist-
ing of an intermetallic (e.g., MgZn2, Mg2Zn11, LiZn4, CuZn5) in a
matrix of Zn-rich solid solution [22]. Ternary combinations can
even add to the existing number of precipitates; e.g., in Zn-3Cu-
xMg (x = 0.1, 0.5, 1), precipitates of CuZn5 and Mg2Zn11 are dis-
persed in the Zn-rich matrix [117]. The difference in the composi-
tion of these phases creates localized micro-galvanic couples that
consequently enhance the corrosion rate of the alloy, as was
reported for Zn-xCu with CuZn5 phase [106], Zn-xAg with AgZn3
precipitates [110], ternary Zn-Cu-Fe with FeZn13, ternary Zn-Cu-
Fe with FeZn13 [120], and Zn–Al–Mg–xBi with the secondary phase,
a-Mg3Bi2 [122]. Increasing alloy content could often lead to an
increase in the relative amount of these second phases or induce
the precipitation of another type of precipitate resulting to further
alterations in the microstructural corrosion dynamics. Another
case was cited by Yang et al. [78] where Mg-induced grain refine-
ment improved the corrosion resistance of 3D-printed Zn-Mg alloy.
The role of Mg2Zn11 in causing galvanic corrosion is still debat-
able, as indicated by the conflicting reports on the corrosion beha-
viour of Zn-Mg alloys. Mostaed et al. [96] suggested that galvanic
corrosion due to Mg2Zn11 enhanced the corrosion rates in
Zn-xMg alloys. In contrast, Vojtech et al. [19] stated that the forma-
tion of galvanic micro-cells between Zn and Mg2Zn11 is highly
unlikely since the two phases possess similar standard potentials.
It is clear that further research is needed to finally ascertain the
relevant corrosion mechanism in the Zn-Mg alloys.
Some elements can improve corrosion resistance by (i) forming
a less conductive and passive oxide on the Zn surface (e.g., MgO,
Mg hydroxyl carbonate) or (ii) by modifying the characteristic of
the Zn corrosion product (e.g., Mg makes simonkolleite less soluble
thus inhibiting anodic reaction) [91,164,174]. For example, For
example, Mostaed et al. [96] suggested that the uniform and
homogenously dispersed Mg2Zn11 in Zn-3Mg induced good corro-
sion resistance due to the formation of a uniform protective layer
of Mg-containing corrosion products. Yang et al. [78] noted similar
improvements in corrosion resistance in 3D-printed Zn-Mg alloys
due to Mg-induced simonkolleite corrosion films. Zhao et al.
[108] reported that the good corrosion resistance after addition
of Li was due to the formation of a thick passive corrosion layer.
6.3.2. Influence of fabrication technique
Compared to its influence on mechanical properties, the impact
of fabrication route on the biodegradability of Zn and Zn alloys is
less predictable. Assuming that there is no change in the chemical
composition, the extent of influence of the fabrication route on the
corrosion behaviour of a metal will ultimately depend on the typeying and fabrication techniques on the mechanical properties, biodegrad-
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grained, homogenous microstructure is expected to have a lower
corrosion rate compared to its coarse-grained counterpart; or a
multi-phase metal is often likely to corrode faster than its single-
phase counterpart as the second phase can promote galvanic
corrosion.
Casting is considered to create a natural, unstrained structure;
hence the cast metal can be a good reference for measuring the
inherent corrosion rates of metals. On the other hand, wrought
processes strain the metal structure, the extent of which depends
on the processing parameters (e.g., amount of working, working
temperature, etc.), and consequently alters the corrosion
behaviour.
In cast Zn alloys, Dambatta et al. [99] noted that homogeniza-
tion improved the corrosion resistance of Zn-3Mg. Homogeniza-
tion (i) dissolved the prevailing dendritic microstructure and
created a uniform dispersion of precipitates, and (ii) reduced cast-
ing defects thus improving microstructure homogeneity in the
alloy. They observed that the corrosion attack on the homogenized
alloy was generally uniform and that the homogenized microstruc-
ture aided the formation of a compact corrosion film that protected
the underlying metal from further degradation.
Wrought processing had different effects on the corrosion beha-
viour of Zn alloys.
Some noted enhancement of biodegradation rate after wrought
processing. Shen et al. [94] reported that extrusion increased the
corrosion rate in cast Zn-1.2Mg, while Liu et al. [115] noted an
increase in corrosion rate after hot-rolling of cast Zn-1Mg-0.1Sr.
Wang et al. [114] also observed an increase in corrosion rate after
mandrel drawing of hot-rolled Zn-5Mg-1Fe. This increase in degra-
dation is often related to the presence of a second phase (inter-
metallic) that creates galvanic micro-cells, such as Mg2Zn11 [94],
MgZn2, and SrZn13 [115]. The galvanic effect can be especially
enhanced if fabrication caused uneven distribution of precipitates
thereby creating regions where there is a low ratio of anode area
to cathode area, such as when coarse or dendritic, anodic precipi-
tates are present [96].
In contrast, other studies reported an improvement in corrosion
resistance after wrought processing. Gong et al. [92] noted a signif-
icant reduction of corrosion rates in cast Zn-1Mg after extrusion.
Dambatta et al. [99] observed similar improvements in corrosion
resistance in homogenized, cast Zn-3Mg after ECAP, while Liu
et al. [116] noticed only a slight decrease in corrosion rate after
hot-rolling of cast Zn-1Mg-0.1Mn. Mostaed et al. [96] noted large
and deep corrosion pits in as-cast compared to fairly uniform cor-
rosion in extruded Zn-Mg alloys. This enhancement in corrosion
resistance is traced to improvements in microstructure such as
(i) general homogenization of chemical distribution [92], (ii) grain
refinement [92,98], (iii) breakdown of large precipitates [92], and
(iv) uniform distribution of intermetallic phase [96,98].
The biodegradability of porous Zn is also of interest, especially if
the metal is considered for tissue-engineered bone scaffold appli-
cations [175]. Hou et al. [127] observed an increase in the
biodegradability of porous Zn with an increasing specific area of
porosities. This is reasonable since corrosion attack is expected to
initiate at any exposed surfaces on the metal [169] (i.e., in the case
of porous Zn, this refers not only to the external surface but also to
the surfaces of the interconnected pores).
It is also useful to understand the possible influence of a rein-
forcing phase on the corrodibility of a Zn-based composite. Yang
et al. [128] noted that as the amount of hydroxyapatite increased
(i.e., from 1, 5, to 10 wt%) the degradation rate of the composite
increased. For example, the corrosion rate of Zn-10HA was about
5 times higher than that of pure Zn. Corrosion pits were found dis-
tributed in the Zn matrix and particle boundaries. They proposed
that the reduction in corrosion resistance was due to the poresPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriaand voids at the interface of Zn and HA agglomerates. These defects
promoted the penetration of the physiological fluid allowed corro-
sion to occur. The presence of these defects is consistent with the
observed reduction in the strength of the composite with increas-
ing HA amount. Furthermore, the addition of HA altered the com-
positional nature of the degradation products, as there was an
observed increase in O, P and Ca amounts in the corrosion layer.
6.4. In vitro biocompatibility of Zn alloys
Table 4 gives a summary of published reports on in vitro bio-
compatibility tests done on different biodegradable Zn and Zn
alloys.
Cytotoxicity tests, which assess the ability of a substance to
destroy living cells, and hemocompatibility tests, which evaluates
the interaction between a substance and blood, are the most com-
monly employed tests to assess Zn biocompatibility. Antibacterial
tests are popular mainly for cases when Zn is alloyed with known
antibacterial elements such as Cu and Ag. Other tests to determine
genotoxicity, mutagenicity, cell functionality, and inflammatory
response have also been conducted on biodegradable Zn.
For cell viability or cell cytotoxicity tests on Zn, human (e.g.,
aortic, osteoblast, osteosarcoma, fibroblast, endothelial) and mur-
ine (e.g., fibroblast, osteoblast) cells were employed. The proper
choice of cell lines used in the test is deemed crucial as results
can give an accurate idea of the applicability of the tested implant
[176]. For example, Cheng et al. [70] suggested that the cytocom-
patibility of Zn with human endothelial cells (ECV304) implies
suitability of the metal in cardiovascular-related applications.
The commonly used cytotoxicity tests are the (i) extract test
(e.g., MTT assay test), which assess the toxicity of soluble sub-
stances from the implant, and the (ii) direct test, which assesses
the viability of cells grown in contact with the implant [177]. These
tests were conducted at exposure times that range from 1 to
7 days.
In hemocompatibility tests, human blood is exposed to the
implant and can yield valuable information such as hemolysis rate,
which is the rate of destruction of red blood cells, platelet mor-
phology, platelet adherence, and dynamic blood clotting.
Different in vitro studies have already concluded on the good
biocompatibility of pure Zn. However, while studies are unani-
mous in confirming the excellent hemocompatibility of Zn, there
are conflicting reports on the cytocompatibility of the biodegrad-
able metal.
Early on, Cheng et al. [70] noted that pure Zn exhibited no cyto-
toxicity to human endothelial cells but reduced the viability of
murine fibroblast cells. Liu et al. [75], Hiebl et al. [76], Li et al.
[88], and Kannan et al. [124] reported no cytotoxicity in pure Zn
even at 100% extract concentration. In contrast, Yang et al.[78],
Kubasek et al. [55], Xiao et al. [103], Murni et al. [93], Tang et al.
[106] and Wang et al. [123] reported cytotoxicity for Zn at 100%
extract concentration, though no cytotoxic effects of Zn were
observed in diluted extracts (50%). It is logical to assume that
the differences in these results may be due to slight differences
in test methodologies, as results of the MTT assay can be influ-
enced by factors such as the type of cell line, exposure time, extract
concentration, and extraction medium [55,177].
On the other hand, the number of studies reporting the in vitro
cytotoxicity of Zn is compelling. Some of these studies observing
cytotoxicity in pure Zn or in other Zn alloys [66,106] have sug-
gested that the high concentration of extract (i.e., 100%) used in
the test was not suitable for biodegradable metals. Previously,
Wang et al. [178] have similarly concluded while studying the
in vitro cytotoxicity of biodegradable Mg. Hence, they proposed a
re-evaluation of the current standard for assessing cytotoxicity
(i.e., ISO 10993) and suggested a minimum of 6 to 10 times extractying and fabrication techniques on the mechanical properties, biodegrad-
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Table 4
Summary of reported in vitro biocompatibility of biodegradable Zn and Zn alloys. The fabrication technique is indicated as follows: W – commercial wrought product, C – casting, E – hot extrusion, SLM – selective laser melting, HR – hot
rolling, PM – powder metallurgy.
Specimen
(Fabrication)
In vitro Biocompatibility Tests Other Important Conclusions Refs.
Cell viability Hemocompatibility Other Tests (antibacterial,
genotoxicty, etc)
Cell line Exposure
time, d
Results
Pure Zn
4 N Zn (W) i. Murine fibroblast cells (L929)
ii. Human endothelial cells
(ECV304)
1, 2, 4 Exhibits no cytotoxicity to
ECV304 cells but significantly
reduces the cell viability of L929
cells
Hemolysis and platelet adhesion
tests showed excellent blood
compatibility
Results indicates Zn may be
suitable for vascular-related
applications
[70]
6 N Zn (W) i. Human endothelial cells
(ECV304)
ii. Murine vascular smooth
muscle cells (VSMC)
3 Exhibits no cytotoxicity to both
type of cells at 100% extract
concentration
Hemolysis tests showed excellent
blood compatibility and no
destructive effect on erythrocyte
[75]
4 N Zn i. Murine fibroblast cells (3T3) 2 Cell viability characteristics
including cellular phenotype,
cell activity, cell proliferation
and cell membrane integrity
showed no cytotoxic effects on
cells
[76]
Zn/Zn+2 i. Human endothelial cells
(HAEC)
ii. Human aortic smooth muscle
cells (AoSMC)
iii. Human dermal fibroblasts
(hDF)
2 i. Cytotoxicity tests show
that LD50 values of
3.5 ppm (50 lM) for
hDF, 4.5 ppm (70 lM)
for AoSMC, and
17.5 ppm (265 lM) for
HAEC
ii. All cell types were able
to attach and proliferate
on Zn surface
i. HAEC showed highest tol-
erance for Zn which indi-
cates suitability to
cardiovascular
applications
ii. Cell attachment, spread-
ing, and migration was
sensitive to Zn+2 concen-
tration, particularly in
the hDF and AoSMC
[84]
Zn+2 Human aorta smooth muscle cell
(HASMC)
1 i. Low concentrations of
Zn+2 (<80 lM) is benefi-
cial to HASMC viability,
adhesion, spreading,
proliferation, and
migration
ii. Above 80 lM, cell health
markers are significantly
reduced
Gene expression profiling showed
that the adversely affected genes
were related to angiogenesis,
inflammation, cell adhesion, vessel
tone, and platelet aggregation
Cellular behaviour and
corresponding biocompatibility is
tightly related to Zn+2
concentrations
[83]
Zn (SLM) Human osteosarcoma cells (MG63) 1, 3, 5 Zn was cytotoxic at 100% extract
(1 and 3 days), non-cytotoxic at
100% at 5 days and 50% dilution
at all exposure times
Cell viability is influenced by the
concentration of the extract and
exposure time
[78]
Zn Antifungal tests showed that C.
albicans colonized on Zn corrosion
products
Simonkolleite corrosion layer was
more effective in inhibiting C.
albicans than zincite
[85]
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Table 4 (continued)
Specimen
(Fabrication)
In vitro Biocompatibility Tests Other Important Conclusions Refs.
Cell viability Hemocompatibility Other Tests (antibacterial,
genotoxicty, etc)
Cell line Exposure
time, d
Results
Binary
Zn-0.05 Mg (E) Murine fibroblast cells (L-929) 1, 3, 5 i. Both Zn and Zn-0.05 Mg
were cytotoxic at 100%
extract; non cytotoxic
at 50% and 10% dilution
ii. Very little difference in
the biocompatibility of
Zn and Zn-0.05 Mg
Both Zn and Zn-0.05 Mg alloy
possess strong antibacterial
activity against E. coli and S.
aureus
i. Cell viability is influenced
by the concentration of
the extract
ii. Cell viability improved
with increasing exposure
time
[103]
Zn-0.8Mg (E) i. Human osteosarcoma cells
(U-2 OS)
ii. Murine fibroblast cells (L929)
1 i. Alloy induced cytotoxic
effects to both cell lines
in 100% and 75% extracts
ii. At 50% dilution, the alloy
was non-cytotoxic to
U2-OS, but cytotoxic to
L929
Alloy is non-genotoxic (comet
assay) and non-mutagenic (Ames
test)
The highest safe Zn+2
concentration is 120 lM for U-2
OS and 80 lM for L929 cell line
[55]
Zn-1 Mg (C) Murine fibroblast cells (L-929) 1, 3 The alloy did not adversely
affect cell viability and can
support cell attachment and
growth
[92]
Zn-1.2Mg (C,E) i. Human osteosarcoma cells
(HOS)
ii. Human osteosarcoma cells
(MG63)
3 i. HOS had cytotoxic reac-
tion at 100, 75 and 50%
dilutions, while MG63
cells had no cytotoxic
response to the alloy
ii. Both cells had better
viability in diluted
extracts
Hemolysis rate test, platelet
adhesion tests, and dynamic blood
clotting tests showed no signs of
thrombogenicity and indicated
excellent hemocompatibility of
alloys
i. Cell viability depended on
the type of cell and the
concentration of extract
ii. Cells had better viability
in as-cast than extruded
alloy
iii. As-cast alloy had lower
hemolysis rate than
extruded one
[94]
Zn-1.5Mg (E) i. Murine fibroblast cells (L929)
ii. Human osteosarcoma cells
(U-2 OS)
1 Pretreatment by incubation
improved cytocompatibility of
the alloy, with osteoblast-like
cell growth observed directly on
the metal surface
[97]
Zn-xMg (x = 1, 2, 3,
4) (SLM)
Human osteosarcoma cells (MG63) 1, 3, 5 Cells exhibited good viability in
all the specimens in 100%
extract, and better viability in
50% extracts of Zn-xMg
i. Cell viability is influenced
by the concentration of
the extract
ii. Cell viability increased
with increasing exposure
time
iii. Increasing Mg increases
biocompatibility of Zn,
with Zn-3Mg exhibiting
best biocompatibility
[78]
Zn-3Mg (C) Human osteoblast cells (NHOst) 3 i. Zn and Zn–3 Mg showed
significant toxicity after
1 day
ii. Cell viability of both
specimens improved at
3 and 7 days
Cell functionality and
inflammatory response tests
showed that the alloy has
acceptable toxicity
i. Addition of Mg enhanced
biocompatibility
ii. Zn was genotoxic and
caused DNA fragmenta-
tion, while Zn-3 Mg was
non-genotoxic
[93]
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Table 4 (continued)
Specimen
(Fabrication)
In vitro Biocompatibility Tests Other Important Conclusions Refs.
Cell viability Hemocompatibility Other Tests (antibacterial,
genotoxicty, etc)
Cell line Exposure
time, d
Results
Zn-1Mg i. Human osteosarcoma cells
(MG63)
ii. Human umbilical vein
endothelial
iii. cells (ECV304)
iv. Murine vascular smooth
muscle cells (VSMC)
3 i. Zn and Zn alloys exhib-
ited no cytotoxic effect
on cell lines
ii. Cell viabilities was
higher in the Zn-1X
alloy compared to pure
Zn
iii. Unhealthy morphology
in cells cultured on pure
Zn, healthy morphology
in cells cultured in bin-
ary alloys
The Zn-1X alloys exhibited good
hemocompatibility, excellent
in vivo anti-platelets adhesion
property, and antithrombotic
properties
i. Cell viability was influ-
enced by the type of cell
line
ii. Ranking in terms of pro-
motion of cell prolifera-
tion: Mg < Ca < Sr
[87]
Zn-1Ca
Zn-1Sr
(HR)
Zn-4Cu (E) human endothelial cell (EA.hy926) 1, 3, 5 The alloy was cytotoxic at 100%
extract; non cytotoxic at 50%
and 10% dilution
Alloy showed good antibacterial
properties against S. aureus, while
inhibiting biofilm formation
Cell viability did not significantly
change with exposure time
[66]
Zn-xCu
(x = 1,2,3,4) (E)
human endothelial cell (EA.hy926) 1, 3, 5 Pure Zn and the Zn-xCu alloys
were cytotoxic at 100% extract;
non cytotoxic at 50% and 10%
dilution
i. Alloys showed good antibacterial
(S. aureus) properties, with
inhibition effect enhanced by
addition of Cu (best results at > 2%
Cu)
i. In 100% extract, pure Zn
and Zn-3Cu possessed
the highest cell viabilities.
ii. No difference in viability
between Zn and Zn-xCu
at 50% and 10%.
[106]
Zn-0.5Al (C) Murine osteoblast precursor cells
(MC3T3-E1)
2, 7 Cells showed good viability in
the binary alloy
The alloy have good antibacterial
activity against E. coli
[118]
Zn-4Mn Murine fibroblast cells (L929) 1, 3, 7 i. Both Zn-Mn alloys were
cytotoxic at 100%
extract; non cytotoxic
at 50% dilution
ii. Cell viability, cell adhe-
sion and cell morphol-
ogy tests confirms Zn-
24Mn has better bio-
compatibility than Zn-
4Mn
Cell viability slightly decreased
with increasing exposure time
[113]
Zn-24Mn
(PM)
Zn-4.0Ag (HR) i. Murine fibroblast cells (L929)
ii. Human primary osteosar-
coma cell (Saos-2)
1, 2 i. Alloy was cytotoxic at
100% extract; noncyto-
toxic at 33%, 16.67%
and 10% dilutions
ii. Alloy showed compara-
ble biocompatibility
with pure Zn
Alloy exhibited good antibacterial
properties against S. gordonii
Cytoxicity depended on cell lines
and type of test (L929 showed
better viability than Saos-2)
[111]
Ternary
Zn-1Mg-0.1Mn Hemolysis and platelet adhesion
tests showed that all specimens
showed good hemocompatibility,
with no signs of thrombogenicity
Hot rolled Zn-1 Mg-0.1Mn
showed lower hemolysis rate than
as cast specimen
[116]
Zn-1.5Mg-0.5Mn
(C)
Zn-1Mg-0.1Mn
(HR)
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Table 4 (continued)
Specimen
(Fabrication)
In vitro Biocompatibility Tests Other Important Conclusions Refs.
Cell viability Hemocompatibility Other Tests (antibacterial,
genotoxicty, etc)
Cell line Exposure
time, d
Results
Zn-1Mg-0.1Sr i. Pure Zn and the ternary
alloys exhibit good
hemocompatibility
ii. Hemolysis rate in the tern-
ary alloy is lower than in
pure Zn
There was no difference in
hemocompatiility between as-
cast and hot-rolled alloy
[115]
Zn-1Mg-0.5Sr
(C)
Zn-1Mg-0.1Sr
(HR)
Zn-3Cu-xMg
(x=0.1, 0.5, 1.0)
(E)
human endothelium-derived cells
(EA.hy926)
1, 3, 5 i. Zn, Zn-3Cu, and Zn-3Cu-
0.1Mg are cytotoxic,
while Zn-3Cu-0.5Mg
and Zn-3Cu-1.0Mg are
non-cytotoxic at 100%
ii. All specimens are non-
cytotoxic at 50% and 10%
i. Cell viability is enhanced
with increasing Mg
content
ii. In 100% extract, in vitro
cytotoxicity of Zn-3Cu-
xMg is better than that of
the pure Zn
iii. In 50% and 10% dilution,
the cytoxicity of Zn and
the ternary alloys are
similar
[117]
Zn-0.5Al-xMg
(x = 0.1, 0.3,
0.5) (C)
Murine osteoblast precursor cells
(MC3T3-E1)
2, 7 i. Cells showed good via-
bility in the ternary
alloy extracts
ii. Addition of Mg (from 0.1
to 0.5 wt%) to the binary
Zn-0.5Al alloy improves
cell viability
Zn-based binary and ternary alloys
have good antibacterial activity
against E. coli
i. Ternary Zn-Al-Mg alloys
samples indicated better
antibacterial property
than binary Zn-0.5Al alloy
against E. coli.
ii. Antibacterial property
iii. increased with increasing
Mg content in the ternary
alloy
[118]
Zn-1Mg-1Ca Human osteosarcoma cells (MG63) 1, 3, 5 Cell viability and cell
morphology tests showed
excellent cell viabilities in Zn
and the Zn ternary alloy extracts
at all exposure times
Both as-cast and as-rolled pure Zn
and ternary alloys exhibited good
hemocompatibility
The ternary alloys exhibits better
cytocompatibility than pure Zn
with the ranking of
biocompatibility as follows:
Zn < Zn–1 Mg–Ca < Zn–1 Mg–
1Sr < Zn–1Ca–1Sr
[88]
Zn-1Mg-1Sr
Zn-1Ca-1Sr
(C, HR)
Quaternary
Zn-0.5Al-0.5 Mg-
xBi (x = 0.1, 0.3.
0.5) (C)
Murine osteoblast precursor cell line
(MC3T3-E1)
2, 7 i. The quaternary alloys
showed no cytotoxic
effects on cells
ii. Cell viability decreased
with increasing Bi
content
[122]
Commercial
ZA4-1 human umbilical vein endothelial
cells (HUVECs)
1, 2, 4 i. All specimens (including
pure Zn) were cytotoxic
at 100% extract concen-
tration, but were non
cytotoxic at 50% dilution
ii. Significantly improved
biocompatibility was
observed in ZA4-1 and
ZA6-1 alloys compared
with pure Zn
Hemolysis and platelet adhesion
tests showed good
hemocompatibility in both pure Zn
and commercial alloys
Commercial alloys have
similar/better viability than Pure
Zn
[123]
ZA4-3
ZA6-1
(W)
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This argument becomes stronger in light of the fact that in vivo
tests have already proven the excellent biocompatibility of Zn
[18]; thus, there is a reason to doubt in vitro tests indicating its
cytotoxicity. However, it is important to mention that in vivo tests
involved much longer exposures times (i.e., months) than those
used in in vitro tests (i.e., days). A study by Yang et al. [78] suggests
that pure Zn’s cytotoxic effect on cells at 100% extract concentra-
tion is only temporary and exist in the short-term. They observed
that Zn (SLM) was cytotoxic to human osteosarcoma cells (MG63)
at 100% extract at 1 and 3 days exposure, but was non-cytotoxic at
5 days. Yang et al.’s conclusions appear to be more consistent with
what was observed from in vivo tests [18,74]. It is possible that the
absence of cytotoxic influence on surrounding tissues reported
from in vivo experiments could be due to the fact that these tests
are often conducted under prolonged exposure times.
In vitro cytocompatibility studies on Zn+2 ions have also been
conducted to determine the limit of tolerance of living cells. Shear-
ier et al. [84] noted that the safe Zn+2 concentration level depends
on the type of cell line, with some cell lines exhibiting better toler-
ance than others. They measured LD50 values of 3.5 ppm (50 lM)
for human dermal fibroblasts (hDF), 4.5 ppm (70 lM) for human
aortic smooth muscle cells (AoSMC), and 17.5 ppm (265 lM) for
human endothelial cells (HAEC). Ma et al. [83], who studied the
cytocompatibility of Zn+2 with human aorta smooth muscle cells
(HASMC), appear to agree with the observations by Shearier et al.
Ma et al. noted that Zn+2 induced a biphasic cellular response from
HASMC. They found that at concentrations of <80 lM Zn+2 is ben-
eficial to HASMC viability, adhesion, spreading, proliferation, and
migration. At Zn+2 concentrations above 80 lM, cell markers are
significantly reduced. This information is important as this defines
the limit of applicability of biodegradable Zn based on the rate of
corrosion and ion release.
Alves et al. [85] noted that the type of corrosion film formed at
the surface influences the antifungal properties of Zn. Initially, they
observed how different species of corrosion products predominate
depending on implant location in the body (i.e., simonkolleite
dominates when the Zn implant is attached to the bone-muscle
interface, and zincite dominates when the implant is inside the
bone). They then reported that the simonkolleite corrosion layer
was more effective in inhibiting C. albicans than zincite.
Murni et al. [93] reported that Zn is genotoxic and caused DNA
fragmentation. Xiao et al. [103] observed that Zn possess antibac-
terial properties against Escherichia coli (E. coli) and Staphylococ-
cus aureus (S. aureus). Ning et al. [179] explained that the
antibacterial properties of Zn originate from its ability to damage
bacterial cell membranes via the generation of reactive O2 species;
while Phan et al. [180] observed Zn ions’ ability to inhibit several
aspects of bacterial activity such as transmembrane proton
translocation, glycolysis, and acid tolerance.
6.4.1. Influence of alloying
In terms of toxicity, Zn is less biocompatible than Mg in that the
upper limit of recommended daily intake is much lower than Mg
[65]. Therefore, it is expected that the addition of Mg would
increase the biocompatibility of Zn.
Numerous in vitro cytocompatibility [55,78,92–94,97,103] and
hemocompatibility [87,94] studies have put forth enough evi-
dences proving the good biocompatibility of different Zn-xMg
alloys (x = 0.05, 0.8, 1.0, 1.2, 1.5, 2, 3, 4). Similar to reports on Zn,
some Zn-Mg alloys [55,93,103] have also been reported to trigger
cytotoxic responses in cells exposed to 100% extract concentra-
tions; though this could be attributed to the perceived incompati-
bility of the current testing standard (i.e., ISO 10993) to
biodegradable metals. Murni et al. [93] also concluded from cell
functionality and inflammatory response tests that Zn-3Mg alloyying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
28 J. Venezuela, M.S. Dargusch / Acta Biomaterialia xxx (xxxx) xxxhas acceptable toxicity, while Xiao et al. [103] observed the
antibacterial qualities of Zn-0.05Mg against E. coli and S. aureus.
Though pure Zn is not as favourable for bone integration as pure
Mg [65,181], several studies confirm that Mg additions to Zn could
promote osseointegration. Li et al. [87] noted that Zn-1Mg stimu-
lated the growth of new bone tissue. Alves et al. [104] concluded
that cast and homogenized Zn-xMg (x = 1, 2) might support
osseointegration due to the formation of Ca phosphate corrosion
layer containing bone-analogous skorpionite and hydroxyapatite.
Some studies suggest that Mg can also improve the genotoxicity
and mutagenicity of Zn. Mutagenicity refers to the introduction of
permanent and transmissible changes in the amount or structure
of the cell’s genetic material (e.g., DNA, RNA), while genotoxicity
refers to the to the ability of substances to damage the cell’s
genetic material without necessarily causing mutation [182]. Indi-
cations of mutagenity could signify that a material is carcinogenic.
Murni et al. [93] reported that Zn was genotoxic (comet assay) as it
induced significant damage to cells after a 7-day exposure test. In
contrast, Zn-3Mg was observed to be non-genotoxic. Kubasek et al.
[55] similarly reported no genotoxic (comet assay) and mutagenic
(Ames test) effect in Zn-0.8Mg.
Li et al. [87] observed that swapping Mg with other IIA elements
such as Ca and Sr in Zn-1Mg created alloys with better biocompat-
ibility than pure zinc. They found that Sr was the best in promoting
the proliferation of human osteosarcoma cells (MG63), followed by
Ca, then Mg. Li et al. [88] also observed that ternary combinations
of Zn with these IIA elements were cyto- and hemocompatible.
They noted that the ranking of biocompatibility; i.e., Zn < Zn–
1Mg–Ca < Zn–1Mg–1Sr < Zn–1Ca–1Sr, were consistent with their
earlier observation than Sr and Ca were more biocompatible than
Mg when combined with Zn.
Some studies reported that the addition of micro-amounts of
Mn (0.1 and 0.5%) [116] or Sr (0.1 and 0.5%) [115] in Zn-1Mg main-
tained the good hemocompatibility of the binary alloy, with the
ternary alloys even exhibiting slightly lower hemolysis rate than
pure Zn.
Copper is another biocompatible element that is essential to
bodily functions. Alloying with Cu does not reduce the good bio-
compatibility of Zn [66,106]. However, it needs to be mentioned
that though these studies conclude good biocompatibility of Zn-
xCu (x = 1, 2, 3, 4) [66,106], these also observed that 100% extracts
from pure Zn and these alloys were cytotoxic and only the 50% and
10% extract dilutions were cytocompatible. Tang et al. [106] further
noted that there is no difference in the viability between Zn and
Zn-xCu at 50% and 10%. Again, the cytotoxicity observed in the
alloys was attributed to the unsuitability of the current test stan-
dard to biodegradable metals. Copper, a known antibacterial ele-
ment [179], appears to impart the same antibacterial qualities to
the Cu-Zn alloy [66,106]. Tang et al. [106] also observed that inhi-
bition effects on (S. aureus) is enhanced by increasing addition of
Cu, with the best results obtained at >2%Cu concentrations.
The addition of Mg to Zn-Cu appears to improve the cytocom-
patibility of the binary alloy. Tang et al. [117] reported that Zn,
Zn-3Cu, and Zn-3Cu-0.1Mg are cytotoxic to human endothelium-
derived cells (EA.hy926) at 100% extract, while Zn-3Cu-0.5Mg
and Zn-3Cu-1.0Mg are non-cytotoxic at the same extract concen-
tration. At 50% and 10% extract dilution, the cytotoxicity of Zn
and the other alloys are similar. It was also noted that cell viability
was promoted despite the increase in corrosion rate after Mg addi-
tion. This means that the beneficial effect of Mg on the cytocom-
patibility of the Zn-Cu alloy may be due to Mg having better
biocompatibility than Cu. This means that though more ions are
released with the enhanced corrosion rate in the Zn-Cu-Mg alloy,
less of the more toxic Cu is present in the extract as it was replaced
by the more benign Mg.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta BiomateriaManganese has also been observed to have positive influences
on the biocompatibility of Zn. Sotoudeh-Bagha et al. [113] noted
that Zn-4Mn and Zn-24Mn were non-cytotoxic to murine osteo-
blast precursor cells (MC3T3-E1) at 50% extract dilution, though
both alloys are cytotoxic at 100% extract concentration. Results
of cell viability, cell adhesion, and cell morphology tests further
confirm that Zn-24Mn has better biocompatibility than Zn-4Mn,
likely due to better corrosion resistance in Zn-24Mn.
Li et al. [111], studying the cytocompatibility of Zn-4.0Ag with
murine fibroblast cells (L929) and human primary osteosarcoma
cell (Saos-2), noted that the addition of silver does not alter the
biocompatibility of Zn. Moreover, Ag adds antibacterial qualities
to biodegradable Zn against Streptococcus gordonii (S. gordonii).
Bakhsheshi-rad et al. [118] reported that alloying with small
amounts of Al (0.5%) retained the good biocompatibility of Zn
and imparted antibacterial properties against E. coli. The addition
of Mg to Zn-Al further improved the biocompatibility of the binary
alloy.
Bakhsheshi-rad et al. [118] noted that the addition of xMg
(x = 0.1, 0.3, 0.5%) improves the viability of murine osteoblast pre-
cursor cells (MC3T3-E1) by reducing the dissolution rate of the Zn-
0.5Al alloy. Additionally, they also observed that increasing Mg
content increased the binary alloy’s antibacterial properties
against E. coli [118]. In another work, Bakhsheshi-rad et al. [122]
found that the addition of xBi (x = 0.1, 0.3, 0.5) to ternary Zn-
0.5Al-0.5Mg alloys showed no cytotoxic effects on murine osteo-
blast precursor cell line (MC3T3-E1); though, cell viability
decreased with increasing Bi content attributed to increased disso-
lution rate of the alloy in the physiological environment.
Wang et al. [123] reported that some of the wrought commer-
cial Zn alloys have good cell viability and hemocompatibility.
Though 100% extracts of commercial Zn alloy and pure Zn showed
toxicity, the 50% diluted extracts were non-cytotoxic to human
endothelial cells. Indeed, ZA4-1 and ZA6-1 alloys displayed better
biocompatibility than pure Zn. Kannan et al. [124] observed that
a commercial ternary alloy, Zn-5Al-4Mg, had no cytotoxic effect
on human alveolar lung epithelial (A549) even at 100% extract con-
centration. These results are significant as these identify alterna-
tive and readily-accessible sources of biodegradable and
biocompatible Zn alloys in the future.
Improvements in the biocompatibility of Zn after alloying addi-
tion may be traced to different factors. Ultimately, cell response in
an in vitro test depends on the quality and quantity of corrosion
products (e.g., ions) released during the degradation of Zn. It is
known that each cell has a unique tolerance level for a specific sub-
stance, and toxicity effects are triggered when this limit is brea-
ched. Some alloying elements such as Mg [55,78] or Ca [87] are
inherently more biocompatible than Zn, and, therefore, cells can
tolerate much higher amounts of these elements than Zn. Conse-
quently, adding such elements to Zn improves the overall biocom-
patibility by a simple principle of displacement; i.e., via the
reduction in the amount of the less biocompatible components
and an increase in the amount of more biocompatible counterparts
in the corrosion product that consequently lowers the cytotoxic
response of the cell. Other alloying elements such as Mn [113], Sr
[87,115] and even Mg [78,93,118] improve biocompatibility by
lowering the degradation rate of Zn and consequently reducing
the total amount of ions released to the physiological environment.
An alloy element’s influence on degradation rate may be traced to
its effect on the microstructure of the most material, as was dis-
cussed in Section 6.3.1. Interestingly, Tang et al. [117] observed
that cell viability was promoted after Mg addition in Zn-3Cu
despite an increase in corrosion rate. This would imply the primacy
of the inherent biocompatibility of the alloying element in deter-
mining the overall biocompatibility of the alloy.ying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
Table 5
Reported in vivo biocorrosion and biocompatibility properties of biodegradable Zn and Zn alloys.
Composition Shape of implant Fabrication
method
Type of host Location In vivo corrosion In vivo biocompatibility Refs.
Exposure
Duration,
months
Corrosion rate CR, lm/yr
Pure Zn
4 N Zn Wire (£ 0.25  15 mm) Commercial
(likely wrought)
Sprague–
Dawley rat
Abdominal aorta 1.5 12 Implant showed good biocompatibility and
antiatherogenic properties
[18]
3 19
4.5 41
6 50
4 N Zn Wire (£ 0.25  10 mm) Commercial
(likely wrought)
Sprague–
Dawley rat
Abdominal aorta 2.5 to 6.5 – Implant showed good biocompatibility, no risk
factor for in-stent restenosis with no
discernible chronic inflammatory response,
necrosis, or hyper-proliferative response
[71]
4 N Zn Wire (£ 0.25  20 mm) Extrusion
+ Drawing
Sprague–
Dawley rat
Abdominal aorta 2 20 Implant showed good biocompatibility;
moderate inflammation with non-obstructive
neointima; neointima thickness is lower in
pure Zn than alloy (Zn-0.1Li)
[107]
4 30
6 19
8 35
10 16
12 23
99.995% Zn Stent (£ 3.0  10 mm); strut
thickness 165 lm
Laser cutting of
microtube
Rabbit Abdominal aorta 1 30 Implant stent showed excellent
biocompatibility; with no severe inflammatory
response, platelet aggregation, thrombosis
formation, and obvious intimal hyperplasia
[86]
3 10
6 15
12 15
4 N Zn Wire (£ 0.25  20 mm) Commercial
(likely wrought)
Sprague–
Dawley rat
Abdominal aorta 1 to 20 25 ± 10 Long-term biocompatibility was observed.
Fibrotic encapsulation allowed for bio-
integration by reducing inflammation while
still promoting biodegradation
[72]
99.9% Zn coated
with PLLA
Wire (£ 0.25  15 and
30 mm)
Commercial
(likely wrought)
Sprague–
Dawley rat
Abdominal aorta 0.5 8 1-lm thin PLLA coating delayed implant
degradation by 6 months; however, PLLA
reduced biocompatibility with signs of toxicity
and active neointima.
[129]
3 10
4.5 20
6 35
Zn Disc (£ 7 mm  2 mm
height)
Gravity casting Wistar rats Subcutaneous
midline of back
3.5 62 Implants showed good biocompatibility
obtained from hematological profiles and
histological analysis.
[188]
6 25
Binary
Zn-1Mg Wire (£ 0.7  5 mm) Hot-rolling C57BL/6
mice
Femoral shaft 2 170 All alloys showed excellent biocompatibility;
alloys promoted new bone formation
[87]
Zn-1Ca 2 190
Zn-1Sr 2 220
Zn-0.002 Mg Wire (£ 0.25  15 mm) Extrusion
+ drawing
Sprague–
Dawley rat
Abdominal aorta 1.5 29 Alloys are sufficiently biocompatible; though
biocompatibility decreased with increasing Mg
content due to enhanced corrosion resistance
by the Mg2Zn11
[102]
3 19
4.5 27
6 32
11 51
Zn-0.005 Mg 1.5 21
3 19
4.5 23
6 30
11 38
Zn-0.08 Mg 1.5 12
3 13
4.5 15
6 27
11 23
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ability and biocompatibility of zinc: A comprehensive review, Acta BiomateriaFinally, it is worth mentioning that the addition of the bioce-
ramic hydroxyapatite (HA) can also improve the in vitro biocom-
patibility of Zn. Yang et al. [128] reported better cell (MC3T3-E1)
viability in Zn-HA composite than in pure Zn. Furthermore, the
composite exhibited excellent hemocompatibility and good
antibacterial qualities against S. aureus.6.4.2. Influence of fabrication technique
Table 4 indicates that most fabrication techniques, i.e., casting,
wrought, P/M, and even additive manufacturing, are viable options
for producing biocompatible Zn and Zn alloys. However, while
there is a considerable number of reports on the influence of alloy-
ing elements on the biocompatibility of Zn, there are very few
reports on the impact of fabrication technique on the biocompati-
bility of Zn. Often a study reports on the biocompatibility of Zn
made via a specific fabrication process only. Due to slight differ-
ences in the details of biocompatibility tests adopted (e.g., different
cell lines, exposure times, extract medium, etc.), it may be difficult
to directly compare biocompatibility results as these differences
influence the results of each test. Therefore, it would be best to
only draw conclusions from results that originate from the same
work.
Reports from four studies are presented here. Shen et al. [94],
who studied the in vitro biocompatibility of Zn-1.2Mg with human
osteosarcoma cells (HOS and MG63), observed that cell viability
and hemocompatibility is better in as-cast than extruded alloy.
This could be related to the increase in corrosion rate of Zn-
1.2Mg after extrusion. Li et al. [87] reported that there was no sig-
nificant difference in the hemocompatibility of as-cast and as-
rolled pure Zn and some Zn ternary alloys (i.e., Zn-1Mg-1Ca, Zn-
1Mg-1Sr, Zn-1Ca-1Sr). Liu et al. [116] noted that hot-rolled Zn-
1Mg-0.1Mn showed better hemocompatibility than its as-cast
counterpart. They did not expound on a reason for this observation.
However, the corrosion rate of the hot-rolled specimen was
slightly lower than the as-cast. In another work, Liu et al. [115]
concluded that there was no difference in hemocompatibility
between as-cast and hot-rolled Zn-1Mg-0.1Sr alloy.
Clearly, the amount of information is not yet enough to justify a
definitive conclusion on the matter. However, one can draw from
other relevant observations. As was observed in alloyed Zn, the
biocompatibility was largely associated to (i) the composition of
the released corrosion products (i.e., toxic or non-toxic) and on
(ii) the corrosion rate, as this dictates the amount of material inter-
acting with the surrounding cells and tissues. Since fabrication
technique influences microstructure, and consequently the
biodegradability of Zn, then it is reasonable to assume that fabrica-
tion technique will also influence, either positively or adversely
depending on the interplay of corrosion product and corrosion rate
on the surrounding tissues, the biocompatibility of the metal. Such
an assumption is consistent with what was observed in other
biodegradable metals [9,183,184].
Physicochemical properties of the surface, specifically wettabil-
ity and surface roughness, can also influence the biocompatibility
of an implant [185,186]. Wettability affects protein adsorption that
is crucial for cell proliferation on the surface of the implant]. It is
believed that moderate hydrophilicity, which is achieved at an
optimal range of surface energy, can enhance cell growth and
improve biocompatibility. Surface roughness influences a number
of physiological phenomenon including cell spreading, cell differ-
entiation, osseointegration as well as biofilm formation. For exam-
ple, high surface roughness is essential to induce tissue and bone
tissue in bone implants. These physicochemical properties are also
dependent on the choice of processing technique, and future stud-
ies are needed to investigate the correlation between surface prop-
erties and biocompatibility of Zn.ying and fabrication techniques on the mechanical properties, biodegrad-
lia, https://doi.org/10.1016/j.actbio.2019.01.035
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There are relatively fewer reports on the in vivo performance
compared to the in vitro performance of Zn and Zn alloys. This dis-
crepancy is understandable as in vitro tests are generally expen-
sive, time-consuming, and complex; hence the reluctance of
researchers to immediately engage in these type of experiments.
However, in vivo tests are indispensable and are considered the
more relevant approach for evaluating the biocorrosion and bio-
compatibility of a candidate implant material [187].
Table 5 shows a summary of in vivo biodegradation and bio-
compatibility reports on several Zn and Zn alloys. The first report
on the in vivo performance of Zn was by Bowen et al. [18] in
2013. They implanted commercially-available 4 N Zn wires into
the abdominal aorta of Sprague-Dawley rays and observed the
implants’ behaviour up to a period of 6 months. They made some
important observations including: (i) the in vivo corrosion rate of
pure Zn ranged from 10 to 50 lm yr1, which is within the ideal
rate of about 20 lm yr1, (ii) the thin, compact corrosion product
of Zn similar to Mg, and (ii) the excellent biocompatibility and
antiatherogenic properties of the Zn implant. They also noted that
Zn, though a promising alternative to Mg in bioabsorbable stent
applications, do not possess sufficient mechanical properties for
this application. Though Bowen et al. were not the first to report
on the biocompatibility of Zn, they were the first to confirm the
in vivo biocompatibility of Zn and paved the way for future work
on this metal. Further works by Bowen et al. [71] on the in vivo bio-
compatibility of Zn led to similar conclusions; i.e., Zn implant
showed good biocompatibility while showing no risk factors for
in-stent restenosis due to the absence of a discernible chronic
inflammatory response, necrosis, or hyperproliferative (hyper-
plasia) response. Early tissue regeneration was also observed
within the footprint of the implant. Zhao et al. [107] also echoed
these observations. They implanted a fabricated, wrought
(extruded and drawn) 4 N Zn wire in the abdominal aorta of
Sprague-Dawley rats and monitored in vivo performance for
12 months. They reported that the Zn implant showed good bio-
compatibility, though with somemoderate inflammation occurring
in the non-obstructive neointima. They further noted that the
neointima thickness formed on pure Zn is lower than those formed
on Zn-0.1Li alloy. Drelich et al. [72] confirmed the long-term (1-
year) biocompatibility of pure Zn, noting that fibrotic encapsula-
tion allowed for bio-integration by reducing the inflammatory
response of the affected tissues. In another work, Drelich et al.
[73] observed the importance of the presence of the oxide film
on the biodegradation of pure Zn. By using an appropriate surface
engineering treatment (e.g., anodizing, electropolishing), the qual-
ity of the oxide films may be altered and consequently lead to tun-
able rates of biocorrosion.
Shomali et al. [129] studied the in vivo degradation of a PLLA-
coated Zn wire. They noted that even a very thin coating of the
biopolymer (1 lm) is effective in delaying Zn degradation by
about 6 months. However, the coating induced a toxic response
from the surrounding tissue indicating a reduction in the biocom-
patibility of Zn after the surface treatment. Studies on polymer
coatings are important in stent technologies as these have already
been proven effective for drug delivery in drug-eluting stents
[29,30].
Aside from pure Zn, the in vivo performances of several Zn
alloys were also reported. A number of these reports involve Zn-
Mg alloys. All the studies on Zn-Mg alloys were unanimous in
declaring the excellent in vivo biocompatibility of this alloy.
Though pure Zn is not as favourable for bone integration as pure
Mg [65], Li et al. [87] noted that hot-rolled Zn-1Mg promoted the
formation of new bone tissues and also displayed excellent
radiopacity. Similarly, Xiao et al. [103] found that hot-rolledPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta BiomateriaZn-0.05Mg did not induce systemic toxicity, possessed antibacte-
rial properties, and promoted bone tissue growth. Jin et al. [102]
observed that increasing Mg content in wrought Zn-xMg
(x = 0.002, 0.00, 0.08) wires decreased the in vivo biocompatibility
but increased the corrosion resistance of the alloy.
Other binary Zn alloys such as Zn-1Ca [87], Zn-1Sr [87], Zn-0.1Li
[107], Zn-Al [109] and Zn-2Fe [188] were all reported to possess
good in vivo biodegradability and biocompatibility. Li et al. [87]
reported that Zn-1Ca and Zn-1Sr were also capable of inducing
new bone growth, similar to Zn-1Mg. Zhao et al. [107] observed
that Zn-0.1Li induced thicker non-obstructive neontima formation
and a higher inflammatory response than pure Zn, indicating a
slight reduction in biocompatibility due to Li. Bowen et al. [109]
noted an interesting in vivo behaviour in Zn-Al alloys. While pure
Zn was noted to degrade starting from the surface towards the
core, the Zn-Al alloys were found to be degraded internally even
in the early stages of corrosion (1.5 mos). Cracks were found at
the core of the alloys, and these grew in size with implantation
time. The implants were found to resist a fibrotic encapsulation
response. Also, the moderate inflammatory response was not
directly due to Al but rather caused by intergranular corrosion.
Only the Zn-Al alloys were particularly susceptible to intergranular
corrosion, driven by micro-anodic sites consisting of Al precipitates
located at the grain boundaries. Finally, Kafri et al. [188] reported
an almost two-fold increase in corrosion rate after the addition
of 2 wt% Fe in Zn.
A majority of the reported in vivo studies involved implanta-
tions in the abdominal aorta, the results of which are targeted
for cardiovascular stent applications. In contrast, only three studies
[87,103,128] reported implantations in bone (i.e., femoral shafts) in
which results are more suitable for orthopedic applications. Also,
one study implanted Zn subcutaneously [188]. It is noteworthy
that the corrosion rate reported for Zn implanted in the femoral
shaft was significantly higher (3X) than for those implants in the
abdominal aorta. Li et al. [87] reported a corrosion rate of about
170–220 mm for Zn-1X (X= Mg, Ca, Sr) implanted in the femoral
shaft of a C57BL/6 mice for a 2-mos implantation time, while the
range of corrosion rate for several types of Zn implants (i.e., Zn,
Zn-Mg, Zn-Al) generally falls in between 10 and 50 um when
implanted in abdominal aorta for a period of 1–12 mos. This obser-
vation suggests the influence of implant location on corrosion rate.
However, it may be argued that this conclusion is premature since
there were some differences in these studies that could account for
this disparity, such as differences in specimen dimension, animal
host, and alloy composition. This issue could be resolved by addi-
tional studies in the future.
The addition of HA appears to increase the in vivo degradation
rate of the Zn-based MMC, consistent with the results of in vitro
degradation tests [128]. HA induced localized corrosion in the
composite, particularly at the Zn-HA interface, in contrast to the
observed uniform corrosion mode in pure Zn. On the other hand,
the Zn-HA composite exhibited excellent in vivo biocompatibility
and was better than pure Zn in stimulating new bone formation.
All of the in vivo studies used a small animal model; i.e., rat,
mice or rabbit. This approach is logical and prepares the ground-
work for future studies in larger models. As studies on biodegrad-
able Zn move forward, it would be interesting to see the in vivo
behaviour of Zn-based implants in larger animals such as pigs or
horses, and eventually in humans.
Reports on the behaviour of the in vivo corrosion rate over time
are also interesting to consider as these appear contradicting.
Bowen et al. [18] noted a non-linear increase in the corrosion rate
of pure Zn with time. The corrosion rate was observed to accelerate
after 3 mos then normalized at 6 mos. In contrast, Drelich et al.
[72] noted a linear increase in cross-sectional area reduction due
to corrosion. Consequently, they measured a fairly steady in vivoying and fabrication techniques on the mechanical properties, biodegrad-
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iod despite the presence of fibrotic encapsulation. Jin et al. [102]
noted that the in vivo corrosion rate of Zn-xMg (x = 0.002, 0.005,
0.08) increased with time, while Zhao et al. [107] observed a fluc-
tuating corrosion rate in pure Zn over a 12 month period and a
steadily increasing corrosion rate in Zn-01Li over the same period.
Kafri et al. [188] reported a drop in the corrosion rate of Zn and Zn-
2Fe after comparing 3.5 and 6 mos implantation times. Yang et al.
[86], who tested the in vivo corrosion performance of an actual
stent, noted that the corrosion rate of the Zn stent decreased over
time and became steady after 6 months. They proposed that this
behaviour is primarily influenced by the physiological changes
occurring in the vicinity of the degrading stent, as previously dis-
cussed in Section 6.2. The difference in the reported results may
be due to slight differences in the experimental details of each
study, and future work may be needed to ascertain which corro-
sion behaviour is accurate.
Finally, most of the in vivo tests reported for Zn used specimens
with simple geometric shapes such as wires or strips. Very few
studies reported on the in vivo behaviour of actual stents, and
there is no report on Zn-based bone fixation devices. The succeed-
ing sections describe the fabrication and the in vivo performance of
Zn stents.6.6. Fabrication and in vivo performance of actual Zn stents
6.6.1. Stent fabrication
There exist several options for creating metallic stents. Often,
the choice of a particular fabrication route depends on the inherent
property of the base metal. For ductile metals like SS or nitinol,
options can range from wire weaving or braiding, laser machining,
and electroforming [189]. Post-processing techniques are
employed to improve cut quality and meet other property require-
ments. These techniques include cleaning, deburring, etching, and
final polishing.
However, for metals with limited ductility like Zn the most fea-
sible approach involves a combination of fabrication techniques.
Stent fabrication starts with creating the hollow microtube. This
preformmay be made using a suitable wrought process (e.g., draw-
ing or extrusion). The microtube is then processed further to create
the necessary stent design. For example, Hiebl et al. [76] and Yang
et al. [86] used laser cutting, while Wang et al. [114] reported onFig. 8. Examples of fabricated vascular Zn stents using a combination of wrought proce
permission from Elsevier) (b) Hiebl et al. (reprinted from [76], with permission from IO
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ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriausing a combination of laser etching and electrochemical polishing
to create the stent. Mostaed et al. [96] further confirmed that the
use of laser cutting does not induce significant changes in the
microstructure and properties of the cut Zn alloy. This implies that
this cutting technique is a feasible process for machining Zn pre-
forms to stents. Fig. 8 shows some examples of fabricated vascular
Zn stents reported in the literature. The in vivo performance of the
laser cut stent fabricated by Yang et al. [86] will be reported in the
succeeding section.
Catalano et al. [190] reported on the fabrication of flat pure Zn
stents by a two-step process involving laser microcutting and
chemical etching. The starting material is a flat sheet that is laser
cut then chemically etched to form a flat mesh. The flat mesh is
later expanded using a balloon catheter to form a 3D tubular shape.
Though the planar stents was successfully fabricated, additional
tests to determine in vivo and in vitro performance is still needed.
Additive manufacturing (aka 3-D printing) techniques remain a
viable option for fabricating stents in the future, especially useful
for creating patient-specific customized implants. Reports on 3-D
printed polymer-based, bioabsorbable vascular stents already exist
[191]. Recently, Wen et al. [80] reported on the successful fabrica-
tion of Zn stents using SLM, as shown in Fig. 9. They used a starting
raw material of nitrogen-atomized pure Zn powder with an aver-
age diameter of 28.2 lm and an oxygen content of 0.98%. These
3D-printed stents had diameters of 5, 4, 3 and 2 mm, with strut
diameters of 500, 300, 300 and 200 lm, respectively. The as-
printed surface roughness of the stent was still unideal but could
be improved with an appropriate finishing technique (e.g., chemi-
cal or electrochemical polishing). It would be interesting to see the
in vivo performance of this 3-D printed stent.6.6.2. In vivo performance of Zn stents
Reports on the performance of actual Zn stents are quite rare.
Early reports on zinc’s in vivo performance did not involve an
actual stent design, but rather reasonably simple shapes such as
wires [18,71,87]. Liu et al. [75] reported testing Zn mini-tubes,
which is the precursor shape of the stent, but these were done
in vitro.
In 2015, Hiebl et al. created a zinc stent prepared by laser cut-
ting. The stent possessed a closed-cell design consisting of inter-
locked stent segments. However, the stent was tested only
in vitro, using a serum-supplemented cell (3T3) culture medium.ssing and laser machining, as reported by (a) Yang et al. (reprinted from [86], with
SPress) (c) Wang et al. (reprinted from [114], with permission from Elsevier).
ying and fabrication techniques on the mechanical properties, biodegrad-
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Fig. 9. The 3D-printed cardiovascular stent produced by Wen et al.: a) sample photo, b) SEM. image, and c) radiographic image. Scale bars for (a) and (b) were improved for
better visibility. Reprinted from [80], with permission from Elsevier.
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microtubes (3 mm outer diameter and 0.2 mm thickness) but
failed to describe the performance of this stent in the report. Sim-
ilarly, Wang et al. [114] cited the successful fabrication of a proto-
type vascular stent from Zn-5Mg-1Fe microtubes. They reported on
the in vitro degradation of the microtube, as well as on the
mechanical behaviour (i.e., balloon expansion capabilities) of the
fabricated stent, but did not describe the in vivo performance of
the stent.
In 2017, Yang et al. [86] published arguably the first report on
the performance of an actual zinc stent tested in vivo. The test
was a one-year study that involved inserting the stent in the
abdominal aorta of a rabbit. Fig. 10 shows some of the images
taken by Yang et al. of the stained section of the abdominal aorta
at different implantation times. Their work resulted in a deeper
understanding of zinc degradation in a physiological environment.Fig. 10. Low and high magnification micrographs of the stained sections of the abdomin
reported by Yang et al. These images show the evolution of neontima around the stent
Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta BiomateriaSignificant findings from this work include: (i) the retention of
mechanical integrity of the zinc stent for 6 months, (ii) the degra-
dation of about 40% (i.e., 41.75 ± 29.72%) of the stent volume after
12 months, (iii) the excellent biocompatibility of the degradation
product of Zn, and (iv) the proposal of an in vivo degradation
mechanism for Zn (discussed in detail in Section 6.2). They noted
the significant influence of the blood vessel’s healing process
(e.g., the formation of neointima) on the degradation behaviour
of Zn. The most important conclusion from this study is the favour-
able recommendation of Zn as a future biodegradable metal for
stent fabrication.
Yang et al. [86] also noted that the corrosion rate of the Zn stent
started high at 30 lm yr1 during the first month, decreased to
10 lm yr1 at the 3rd month, then steadied to about 15 lm yr1
at the 6th and 12th months. This was owing to the formation of
neointima that protected the implant from the typical aggressiveal aorta of a rabbit after 1, 3, 6 and 12 months implantation of the pure Zn stent, as
struts over time. Reprinted from [86], with permission from Elsevier.
ying and fabrication techniques on the mechanical properties, biodegrad-
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in contrast to some previous observations on Zn implants in which
the formation of neointima did not adversely affect the degrada-
tion rate. For example, Guillory et al. [74] stated that the Zn
implant degradation was higher in the covered areas (i.e., regions
facing the arterial wall) than in the exposed sections (i.e., those
in contact with flowing blood). Open contact with blood tended
to passivate the metal surface and reduce the rate of degradation.
Drelich et al. [72] noted a steady corrosion rate despite fibrotic
encapsulation of the Zn implant. The difference in these observa-
tions may be due to the difference in implant geometry; i.e., wires
vs. actual stents. Indeed, the dimension of the implanted wires was
set to be similar to the typical aspect of a stent strut, with the idea
that the wire would simulate the behaviour of a single strut. How-
ever, though cross-sectional areas of the wire and the strut were
comparable, the shapes are different. Struts are typically quadrilat-
eral (square or rectangular) while the implanted wires were circu-
lar. The difference in the exposed surface area could have
influenced the corrosion behaviour of the implant; i.e., higher cor-
rosion rates are favoured for shapes with higher surface area. Fur-
thermore, the stent applied a radial force on the arterial wall
during service whereas the implanted wires were non-load bear-
ing. The influence of such stress could have been two-fold: (i)
altered the degradation behaviour of the Zn implant, and (ii) chan-
ged the response of the affected arterial wall by causing localized
endothelial damage.
6.7. Critical evaluation
The high number of positive reports on the biocompatibility of
Zn and Zn alloys proves undoubtedly that the metal has consider-
able potential in the fabrication of biodegradable implants. In
terms of biodegradability and biocompatibility, again it is the Zn-
Mg alloys that appear to offer the most promise. Magnesium, by
virtue of its excellent biocompatibility, enhances the biocompati-
bility of Zn. Also, the ability of the Zn-Mg alloy to promote bone
growth makes it suitable for orthopedic applications. Though
reports contradict on how Mg influences the biodegradability of
Zn, such issues may be resolved by future studies. It is also antici-
pated that better control of composition and microstructures could
allow finer tuning of the alloy’s corrosion rate.
There is still no definite conclusion on how processing affects
the biocompatibility of Zn due to the shortage of publications on
the matter. At best, the influence of processing on biocompatibility
may be linked with how processing affects microstructure and
biodegradability. For now, wrought processing would still be the
best option as it is not found to have an adverse influence on
biodegradability and biocompatibility of Zn, and offers improve-
ments on mechanical properties.
One issue that is important to address is the establishment of
standards that are suitable for assessing degradability and biocom-
patibility of bioabsorbable metals. As was discussed previously,
corrosion results from different in vitro tests are not ideal for com-
parison due to differences inmethodologies. In other cases, some Zn
and Zn alloys were observed to elicit a cytotoxic response from bio-
logical cells exposed to 100% concentration extracts [66,106]. This
was attributed similarly attributed to the unsuitability of the test
methodology for assessing biodegradable Zn. Clearly, a lot of ambi-
guity in the interpretation of these results would have been avoided
if the proper test standards were in place and duly adopted.
In August 2018, the latest version of ISO-10993-1, Biological
Evaluation of Medical Devices—Part 1: Evaluation and Testing
within a Risk Management Process [192] was released. This stan-
dard is the most commonly used for assessing biocompatibility
of medical device materials. The new standard has now placed
greater emphasis on risk management process (i.e., biologicalPlease cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
ability and biocompatibility of zinc: A comprehensive review, Acta Biomateriasafety planning and implementation process), together with char-
acterization of the biomaterial. Particularly useful are the changes
done in Table 1 of Annex A, Evaluation tests for consideration, of
ISO-10993-1. This table is now normative and includes six addi-
tional test categories (physical and/or chemical information, mate-
rial mediated pyrogenicity, chronic toxicity, carcinogenicity,
reproductive/developmental toxicity, and degradation) [193].
Unlike in previous versions where several mandatory tests are
identified, the current version has only one mandatory test
requirement (i.e., chemical characterization), and other toxicologi-
cal evaluations are decided on a case-by-case basis within a risk
assessment framework. More importantly, it also includes infor-
mation on the assessment of bioabsorbable materials.
There are other standards containing provisions for bioab-
sorbable metals, such as ASTM F1983-14, ‘Standard Practice for
Assessment of Selected Tissue Effects of Absorbable Biomaterials
for Implant Applications’ [194], and ISO/TR 37137, ‘Cardiovascular
biological evaluation of medical devices – Guidance for absorbable
implants’[195]. Several standards are also under development
[196,197]. This suggests that the standards development organiza-
tions (e.g., ASTM, ISO) are beginning to see the importance of
biodegradable materials in future medical applications. The contin-
ued development of more standards requires the availability of
experimental methods that yield results that are highly repro-
ducible. The academe could certainly take the lead in pushing for
this agenda, but the cooperation of other stakeholders (i.e., stan-
dards development body, medical field, industry) is essential for
this effort to succeed [197].
Finally, a short but critical discussion on the issue of conducting
in vivo or in vitro tests to assess the biocompatibility of biodegrad-
able Zn is presented.
Biocompatibility is probably the most important property to
ascertain for a candidate biomaterial. As mentioned, the term bio-
compatibility is broad and complex; hence proving the biocompat-
ibility of a material requires assessing not only a single property
but several properties. This also means that proving biocompatibil-
ity in materials is arduous, complicated, and expensive if not con-
ducted with prudence. It is therefore essential for researchers to
ascertain the value of performing either of the two types of bio-
compatibility test (i.e., in vivo or in vitro test). A lot of resources
would be saved if researchers can discern when in vitro tests are
worth doing or when it is better to skip in vitro testing and jump
straight to in vivo experiments. To add some historical context, it
is interesting to mention that Bowen’s breakthrough in vivo study
on Zn was conducted without the aid of substantial prior knowl-
edge on the in vitro biocompatibility of the metal.
Both in vivo and in vitro testing have unique advantages and
limitations. Since in vitro tests do not involve a living host, these
tests are relatively simple, easy to implement, inexpensive to con-
duct, can be standardized, and amenable for large-scale screening
[156,187]. Also, in vitro tests often involves only one type of cell,
thus tests are easy to control, and results are easy to interpret.
However, the relevance of in vitro tests results to in vivo perfor-
mance is often questionable, and this is due to some limitations
inherent to in vitro testing [156,177,198]. For example, a review
by Sanchez et al. [199] stated that the measured in vivo corrosion
rate for biodegradable Mg is about 1 to 4 times lower than the
in vitro corrosion rate, which is attributed to the in vitro tests’
inability to accurately mimic the complex physiological conditions
found in vivo. As a consequence, comparison of in vivo and in vitro
biocorrosion results, and even comparison of results of in vitro cor-
rosion tests gleaned from disparate techniques, is ill-advised - a
view which is similarly shared by other researchers [21].
In vivo tests using animal models are known to give more rele-
vant information than in vitro tests as these provide a close
approximation to human response. This implies that results canying and fabrication techniques on the mechanical properties, biodegrad-
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typically involve a single type of cell culture, while in vivo tests
involve multi-cellular environments that display complex systemic
interactions. Consequently, a more comprehensive response is
obtained from in vivo tests [187]. However, the test is expensive,
time-consuming, difficult to control, involves addressing the ethics
of conducting research with animals, and sometimes results are
difficult to interpret and quantify [187].
There is also an ongoing debate of the usefulness and applicabil-
ity of animal tests [200]. Barnard and Kaufmann [201] suggested
that animal experiments are poorly suited to address medical
research needs and can even mislead researchers to wrong conclu-
sions. They cited several historical cases to prove their argument.
For example, they cited one case where a research team found that
25 compounds that were effective in reducing the damage of
ischemic stroke in different animal models (e.g., rodents, cats,
etc.) were completely ineffective to humans. Another is a case
where scientists deduced from animal experiments that inhalation
of tobacco smoke does not cause cancer.
In contrast, Botting and Morrison [202] defended the use of ani-
mal experiments. They cited the many contributions that this prac-
tice made to the advancement of medicine; from the pioneering
work by Pasteur on identifying the role of microorganism in caus-
ing diseases, to subsequent studies of scientists on establishing
causes and vaccines for numerous diseases (e.g., diphtheria, teta-
nus, rabies, tuberculosis, poliomyelitis, etc.), to the development
of open heart surgeries and replacement heart valves, to kidney
dialysis and kidney transplantations. They concluded that a major-
ity of misconceptions about animal research that lead to the wide-
spread activism against such practice could be cleared by a proper
and thorough examination of the literature.
Clearly, there are numerous strong arguments for and against
the practice of animal experiments, though one cannot deny that
this practice has been beneficial to humans. To completely aban-
don in vivo animal testing may be too rash, and could lead to a
regression in the rate of advancement in medicine. Interestingly,
some hold the view that animal experiments, because of their irrel-
evance, have actually retarded progress. They argued that had ani-
mal research been outlawed earlier, researchers would have been
forced to be creative and superior technologies would have
resulted. A good example is the emergence of an in vitro test that
used a reconstructed human skin (i.e., Corrositex) to test biocorro-
sivity [203]. It replaced the traditional tests where the substance is
applied in on a rabbit’s shaved back to determine how far it eats
into the skin. This debate is indeed difficult to settle and time
may tell how this will be resolved [200].
So is the way to go in vivo or in vitro? The answer is not as
clear-cut. What is certain is that it will be foolish to assume that
these tests are mutually exclusive. It may be better to assume that
they are complementary. At this point, it is also reasonable to
declare that in vitro tests should precede in vivo testing, and
in vivo animal testing should precede human testing.
We believe the challenge lies in judging how best to implement
each type of test.
For assessing in vitro biocompatibility, test options are numer-
ous (e.g., cytocompatibility, hemocompatibility, mutagenicity,
antibacterial test, etc.). Sometimes, the assessment of a single
property can even be performed via several methods. For example,
cytotoxicity can be tested using direct, indirect and extraction
methods, and accuracy of results depends on the type of test
adopted [177]. Thus, it is vital that users need to know which
one of these are relevant, and decide howmuch information is nec-
essary before in vivo tests are justified. The standard ISO-10993-
1:2018 would be a good reference for researchers trying to decide
which in vitro biocompatibility tests are appropriate to perform on
a candidate material.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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essential to choose essential parameters such as the type of animal
model to employ, the test duration, and the implant location. Con-
cerning physiology, it is claimed that humans are identical to lab-
oratory animals [202], yet the choice of animal subjects should still
be determined by the scientific question at hand [203]. Anti-animal
research proponents argue that animals in the laboratory do not
undergo the same conditions as humans and, hence, the irrele-
vance of subsequent results. But animal experiments are funda-
mentally not designed to be so [202]. Instead, in vivo testing
provides a means for studying a procedure. However, it does
require meticulous interpretation of results to avoid misrepresen-
tation of one’s work.7. Concluding remarks: research gaps and future directions
A number of foundational research studies have already estab-
lished the tremendous potential of Zn as the next-generation,
biodegradable metallic material. Substantial work has also been
undertaken to understand the relevant properties of Zn for biomed-
ical applications. Current literature suggests that the wrought Zn-
xMg alloy (x < 1.5%) offers the best combination of mechanical
strength, biodegradability, and biocompatibility. Improved control
of processing techniques could optimize concomitant microstruc-
tures and further enhance the properties of this Zn alloy.
However, while Mg-based implants are already commercially
available, rapid adoption of Zn in implant fabrication is not yet
foreseeable. Compared to the amount of knowledge gained in
biodegradable Mg, knowledge in Zn is still wanting. Several issues
need to be addressed before the successful adoption of this metal
in biomedical implant applications. The following lists some of
the issues and some future research directions in this field:
i. Creation of test standards for biodegradable metals
As mentioned in an earlier discussion, one issue that needs to be
addressed is the lack of test standards that are appropriate to
assess the properties (e.g., biocorrosion, cytotoxicity) of biodegrad-
able metals. This idea is not entirely new and has already been
espoused by many researchers [9,178,197].
The existence of such standards will significantly contribute to
the advancement of research in biodegradable Zn. One immediate
benefit of having a standard is it would allow valid comparisons
between results of different studies; hence research gaps will be
easily identified. Subsequent studies can then be refocused on
areas of concern and will result in the exponential growth of
knowledge on the field of biodegradable materials.
ii. Age-hardening and strain-rate sensitivity of Zn
Jin et al. [102] have proven the age-hardening and strain rate
sensitivity of certain biodegradable Zn-Mg alloys. Both phenomena
bear important implications for mechanical properties, and would
consequently influence the processability and applicability of the
metal. Therefore, studying this behaviour should be an important
consideration in future works on Zn and alloys.
iii. Biodegradable micro- and nano-porous Zn
Another possible application of biodegradable Zn is in making
resorbable scaffolds for bone tissue engineering. This application
requires an open cell pore structure akin to cancellous or spongy
bone microstructure. Early studies by Capek et al. [126] and Hou
et al. [127] on the fabrication of porous Zn implants showed
promising results. These studies primarily involved using powderying and fabrication techniques on the mechanical properties, biodegrad-
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option for making open-cell microporousmaterials, and it would be
interesting to see the properties of Zn fabricated via this process.
On the other hand, nano-scale alterations (e.g., hierarchical
design) of metal surfaces are proven effective in enhancing cell
attachment and proliferation on implants [205]. In biodegradable
metals, nanoporous surfaces have been produced via dealloying
or micro-arc oxidation [206].
iv. Application of advanced fabrication techniques
As highlighted in this work, the properties of biodegradable Zn
are inherently dependent on the manufacturing method. While
conventional forming techniques (i.e., casting, rolling, extrusion
and drawing) have been thoroughly studied, it would be interest-
ing to see how other advanced fabrication techniques can influence
the properties of biodegradable Zn. The use of additive manufac-
turing techniques, in particular, selective laser melting (SLM), has
started to gain considerable attention and offers tremendous pro-
mise [79,80,133,134]. Other fabrication methods such as electron
beammelting (EBM) [207] and electroforming [208] are also viable
and could offer some unique benefits.
v. Understanding the influence of surface treatment on
biodegradable Zn
Surface treatment techniques can significantly alter the proper-
ties of a material. This surface treatment can be a coating or some-
thing that alters the mechanical and chemical behaviour of the
material. Polymer coatings are especially popular for creating
drug-eluting stents, and some studies are beginning to see how
these coatings can affect biodegradable Zn. For example, Shomali
et al. [129] have already reported on the in vivo performance of
PLLA-coated Zn alloy. The application of biodegradable metal coat-
ing (e.g., Zn-coated Mg, Zn-coated Fe) on existing biodegradable
metals is also worth considering. This combination of biodegrad-
able metals could offer some unique properties that are not avail-
able in any of its single metal components. It will also be
interesting to see how some of the advanced surface treatments,
such as plasma surface engineering [209], and electrochemical
polymerisation, that have been previously applied to biomaterials
can alter the properties of Zn.
vi. Understanding the influence of physiological elements on Zn
corrosion
Though some outstanding work has been performed to under-
stand the corrosion mechanisms of Zn in vivo, several aspects are
not yet completely understood. For example, in a recent study on
biodegradable Fe-based implants after prolonged in vivo exposure
[59], it was noted that O2 concentration had a significant influence
on the corrosion behaviour of the metal. Hence, due to the differ-
ence in the O2 concentration between in vitro and in vivo tests,
the measured rates of corrosion for biodegradable Fe in these
two tests are significantly dissimilar. A comprehensive under-
standing of the influence of elements (e.g., O2), ions (e.g., Cl,
CO3, HPO4), and compounds (e.g., CO2) present in the physiological
environment on the corrosion mechanism of Zn could be the key to
explaining the significant difference between in vitro and in vivo
corrosion, and allow accurate prediction of the service perfor-
mance of the metal.
vii. An in vitro test that accurately replicates in vivo test results
A lot of effort has been made to create an in vitro test apparatus
that could precisely match the in vivo performance of implants.Please cite this article as: J. Venezuela and M. S. Dargusch, The influence of allo
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field, as it will simplify and will bring down the cost of biocompat-
ibility testing. Some examples of these apparatus include the
pseudo-physiological test bench proposed by Levesque et al.
[210] or the stentable in vitro artery by Antoine et al.[211]. Both
were used for understanding in vitro stent performance and poten-
tially offer tremendous help in the design and development of
future endovascular devices.
Identifying and replicating the relevant microenvironment
specific to the biomedical application is one of the keys in creating
such an in vitro test [212], but this is certainly difficult. Indeed,
some in the scientific community believe that the tremendous
technological challenge in creating this test is due to the fact that
an isolated and cultivated cells’ behaviour is significantly different
from the corresponding cell’s behaviour inside of the human body
[156,213]. Some even suggest that the body of knowledge neces-
sary for creating this type of in vitro test is centuries rather than
decades away [198]. Though the task appears daunting, efforts to
develop this technology needs to continue since the benefits of
such a device would be enormous.
In line with the development of in vitro tests for biodegradable
metals is the push towards standardization of these tests.
viii. Establishing the accurate mechanical property requirements
specific to a medical application
A lot of research has been performed to improve the mechanical
properties of Zn in order to meet the minimum standard require-
ments of specific biomedical applications. However, as cited ear-
lier, some of the recent commercially-available, absorbable stents
are composed of a material with properties that appear to be ‘sub-
standard’, i.e., having properties inferior to the required 300 MPa
UTS and 18% elongation at fracture ductility for stent applications.
If the medical community already embraces mechanically ‘sub-
standard’ materials, then it means that it may be a good time to
re-evaluate the adopted standards. Establishing a more accurate
and relevant standard value will allow for precise screening of
future biomaterials.Acknowledgement
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